Patent Grant
11974841
The “piezoelectric effect” is the appearance of an electric potential and current across certain faces of a crystal when it is subjected to mechanical stresses. Due to their capacity to convert mechanical deformation into an electric voltage, piezoelectric crystals have been broadly used in devices such as transducers, strain gauges and microphones. However, before the crystals can be used in many of these applications they must be rendered into a form which suits the requirements of the application. In many applications, especially those involving the conversion of acoustic waves into a corresponding electric signal, piezoelectric membranes have been used.
Piezoelectric membranes are typically manufactured from polyvinylidene fluoride plastic film. The film is endowed with piezoelectric properties by stretching the plastic while it is placed under a high-poling voltage. By stretching the film, the film is polarized and the molecular structure of the plastic aligned. A thin layer of conductive metal (typically nickel-copper) is deposited on each side of the film to form electrode coatings to which connectors can be attached.
Piezoelectric membranes have a number of attributes that make them interesting for use in sound detection, including: a wide frequency range of between 0.001 Hz to 1 GHz; a low acoustical impedance close to water and human tissue; a high dielectric strength; a good mechanical strength; and piezoelectric membranes are moisture resistant and inert to many chemicals.
Respiratory rate can be calculated from an acoustic input signal using time domain and frequency domain techniques. Confidence in the calculated respiratory rate can also be calculated using time domain and frequency domain techniques. Overall respiratory rate and confidence values can be obtained from the time and frequency domain calculations. The overall respiratory rate and confidence values can be output for presentation to a clinician.
For purposes of summarizing the disclosure, certain aspects, advantages and novel features of the inventions have been described herein. It is to be understood that not necessarily all such advantages can be achieved in accordance with any particular embodiment of the inventions disclosed herein. Thus, the inventions disclosed herein can be embodied or carried out in a manner that achieves or optimizes one advantage or group of advantages as taught herein without necessarily achieving other advantages as can be taught or suggested herein.
Throughout the drawings, reference numbers can be re-used to indicate correspondence between referenced elements. The drawings are provided to illustrate embodiments of the inventions described herein and not to limit the scope thereof.
Various embodiments will be described hereinafter with reference to the accompanying drawings. These embodiments are illustrated and described by example only, and are not intended to be limiting.
Acoustic sensors, including piezoelectric acoustic sensors, can be used to measure breath sounds and other biological sounds of a patient. Breath sounds obtained from an acoustic sensor can be processed by a patient monitor to derive one or more physiological parameters of a patient, including respiratory rate. For purposes of illustration, this disclosure is described primarily in the context of respiratory rate. However, the features described herein can be applied to other respiratory parameters, including, for example, inspiratory time, expiratory time, inspiratory to expiratory ratio, inspiratory flow, expiratory flow, tidal volume, minute volume, apnea duration, breath sounds (including, e.g., rales, rhonchi, or stridor), changes in breath sounds, and the like. Moreover, the features described herein can also be applied to other physiological parameters and/or vital signs derived from physiological sensors other than acoustic sensors.
Referring to the drawings,
Turning to
The one or more processors 19 can communicate the processed signal to the display 11. In an embodiment, the display 11 is incorporated in the physiological monitor 17. In another embodiment, the display 11 is separate from the physiological monitor 17. In one embodiment, the monitoring system 10 is a portable monitoring system. In another embodiment, the monitoring system 10 is a pod, without a display, that is adapted to provide physiological parameter data to a display.
For clarity, a single block is used to illustrate the one or more sensors 13 shown in
In some embodiments of the system shown in
As shown in
In some embodiments, the ground signal is an earth ground, but in other embodiments, the ground signal is a patient ground, sometimes referred to as a patient reference, a patient reference signal, a return, or a patient return. In some embodiments, the cable 25 carries two conductors within an electrical shielding layer, and the shielding layer acts as the ground conductor. Electrical interfaces 23 in the cable 25 can enable the cable to electrically connect to electrical interfaces 21 in a connector 20 of the physiological monitor 17. In another embodiment, the sensor assembly 13 and the physiological monitor 17 communicate wirelessly.
The sensor connector subassembly 105 can be removably attached to an instrument cable 111 via an instrument cable connector 109. The instrument cable 111 can be attached to a cable hub 120, which includes a port 121 for receiving a connector 112 of the instrument cable 111 and a second port 123 for receiving another cable. In certain embodiments, the second port 123 can receive a cable connected to a pulse oximetry or other sensor. In addition, the cable hub 120 could include additional ports in other embodiments for receiving additional cables. The hub includes a cable 122 which terminates in a connector 124 adapted to connect to a physiological monitor (not shown).
The sensor connector subassembly 105 and connector 109 can be configured to allow the sensor connector 105 to be straightforwardly and efficiently joined with and detached from the connector 109. Embodiments of connectors having connection mechanisms that can be used for the connectors 105, 109 are described in U.S. patent application Ser. No. 12/248,856 (hereinafter referred to as “the '856 Application”), filed on Oct. 9, 2008, which is incorporated in its entirety by reference herein. For example, the sensor connector 105 could include a mating feature (not shown) which mates with a corresponding feature (not shown) on the connector 109. The mating feature can include a protrusion which engages in a snap fit with a recess on the connector 109. In certain embodiments, the sensor connector 105 can be detached via one hand operation, for example. Examples of connection mechanisms can be found specifically in paragraphs [0042], [0050], [0051], [0061]-[0068] and [0079], and with respect to FIGS. 8A-F, 13A-E, 19A-F, 23A-D and 24A-C of the '856 Application, for example.
The sensor connector subassembly 105 and connector 109 can reduce the amount of unshielded area in and generally provide enhanced shielding of the electrical connection between the sensor and monitor in certain embodiments. Examples of such shielding mechanisms are disclosed in the '856 Application in paragraphs [0043]-[0053], [0060] and with respect to FIGS. 9A-C, 11A-E, 13A-E, 14A-B, 15A-C, and 16A-E, for example.
In an embodiment, the acoustic sensor assembly 101 includes a sensing element, such as, for example, a piezoelectric device or other acoustic sensing device. The sensing element can generate a voltage that is responsive to vibrations generated by the patient, and the sensor can include circuitry to transmit the voltage generated by the sensing element to a processor for processing. In an embodiment, the acoustic sensor assembly 101 includes circuitry for detecting and transmitting information related to biological sounds to a physiological monitor. These biological sounds can include heart, breathing, and/or digestive system sounds, in addition to many other physiological phenomena.
The acoustic sensor 115 in certain embodiments is a biological sound sensor, such as the sensors described herein. In some embodiments, the biological sound sensor is one of the sensors such as those described in the '883 Application. In other embodiments, the acoustic sensor 115 is a biological sound sensor such as those described in U.S. Pat. No. 6,661,161, which is incorporated by reference herein in its entirety. Other embodiments include other suitable acoustic sensors.
The attachment sub-assembly 104 includes first and second elongate portions 106, 108. The first and second elongate portions 106, 108 can include patient adhesive (e.g., in some embodiments, tape, glue, a suction device, etc.). The adhesive on the elongate portions 106, 108 can be used to secure the sensor subassembly 102 to a patient's skin. One or more elongate members 110 included in the first and/or second elongate portions 106, 108 can beneficially bias the sensor subassembly 102 in tension against the patient's skin and reduce stress on the connection between the patient adhesive and the skin. A removable backing can be provided with the patient adhesive to protect the adhesive surface prior to affixing to a patient's skin.
The sensor cable 107 can be electrically coupled to the sensor subassembly 102 via a printed circuit board (“PCB”) (not shown) in the sensor subassembly 102. Through this contact, electrical signals are communicated from the multi-parameter sensor subassembly to the physiological monitor through the sensor cable 107 and the cable 111.
In various embodiments, not all of the components illustrated in
Additional information relating to acoustic sensors compatible with embodiments described herein, including other embodiments of interfaces with the physiological monitor, are included in U.S. patent application Ser. No. 12/044,883, filed Mar. 7, 2008, entitled “Systems and Methods for Determining a Physiological Condition Using an Acoustic Monitor,” (hereinafter referred to as “the '883 Application”), the disclosure of which is hereby incorporated by reference in its entirety. An example of an acoustic sensor that can be used with the embodiments described herein is disclosed in U.S. patent application Ser. No. 12/643,939, filed Dec. 21, 2009, titled “Acoustic Sensor Assembly,” the disclosure of which is hereby incorporated by reference in its entirety.
Other types of filters may be included in the filter 202. For example, the filter 202 may include a low pass filter that attenuates high frequency signals. It may be desirable to reject high frequency signals because such signals often include noise. In certain embodiments, the filter 202 includes both a low pass filter and a high pass filter. Alternatively, the filter 202 may include a band-pass filter that simultaneously attenuates both low and high frequencies.
The output from the filter 202 is split in certain embodiments into two channels, for example, first and second channels 203, 205. In other embodiments, more than two channels are used. For example, in some embodiments three or more channels are used. The filter 202 provides an output on both first and second channels 203, 205 to a gain bank 220. The gain bank 220 can include one or more gain stages. In the depicted embodiment, there are two gain stages 204, 206. A high gain stage 204 amplifies the output signal from the filter 220 to a relatively higher level than the low gain stage 206. For example, the low gain stage 206 may not amplify the signal or can attenuate the signal.
The amplified signal at both first and second channels 203, 205 can be provided to an analog-to-digital converter (ADC) 230. The ADC 230 can have two input channels to receive the separate output of both the high gain stage 204 and the low gain stage 206. The ADC bank 230 can sample and convert analog voltage signals into digital signals. The digital signals can then be provided to the DSP 208 and thereafter to the display 210. In some embodiments, a separate sampling module samples the analog voltage signal and sends the sampled signal to the ADC 230 for conversion to digital form. In some embodiments, two (or more) ADCs 230 may be used in place of the single ADC 230 shown.
The acoustic sensor 302 is configured to detect sounds emanating from within a medical patient. For example, the acoustic sensor 302 is often configured to detect the sound of a medical patient's respiration (including inhalation and exhalation), as well as other biological sounds (e.g., swallowing, speaking, coughing, choking, sighing, throat clearing, snoring, wheezing, chewing, humming, etc.). The acoustic sensor 302 can include any of the sensors described herein.
The acoustic sensor 302 may include pre-amplification circuitry (not shown) to generate an output signal, or signals, in response to detected sounds. In some cases, high amplitude (e.g., loud) detected sounds can cause the sensor to saturate. For example, the high amplitude input signal could cause a pre-amplifier having a predetermined, fixed gain setting to saturate. In such cases, meaningful acoustic information detected by the sensor 302 simultaneously with the high amplitude sounds could be lost. To avoid losing such information, the acoustic sensor 302 can include a second pre-amplifier that has a lower, predetermined, fixed gain setting. The sensor 302 provides both high and low gain outputs over separate channels 306, 308 to the physiological monitor. As will be discussed later, the physiological monitor 304 can be configured to switch its input stream between the high and low gain channels 306, 308 depending upon whether a sensor saturation event has occurred, or appears likely to occur.
The data collection processor 312 pre-processes the signals received from the sensor 302 in preparation for further analysis. In one embodiment, the data collection processor 312 includes one or more of a gain amplifier 318, an analog-to-digital converter 320, a decimation module 322, a filtering module 324, and a storage module 326.
A gain amplifier 318 is configured to increase or decrease the gain on the incoming data signal. An analog-to-digital converter 320 is configured to convert the incoming analog data signal into a digital signal. A decimation module 322 is configured to reduce the quantity of data associated with the digitized analog input signal.
For example, the sensor 302 can provide a continuous analog signal to the analog-to-digital converter 320. The analog-to-digital converter 320 outputs a digital data stream having a relatively high data rate. For example, in one embodiment, the analog-to-digital converter 320 provides a digital signal at 48 kHz. The decimation module 322 receives the high data rate data, and can reduce the data rate to a lower level. For example, in one embodiment the decimation module 322 reduces the data rate to 4 kHz or 2 kHz. Reducing the data rate advantageously reduces the processing power of the physiological monitor, in certain embodiments, as the high bandwidth data from the analog-to-digital converter 320 may not be necessary or useful for further respiratory processing. The decimation module 322 can also reduce and/or eliminate unwanted noise from the digitized respiratory signal. A filtering module 324 provides further signal filtering and/or cleaning, and a storage module 326 stores the filtered, digitized input respiration signal for further processing.
A respiration processor 314 analyzes the digitized input respiration signal to determine various physiological parameters and/or conditions. For example, the respiration processor 314 is configured to determine one or more of the respiration rate of the patient, inspiration time, expiration time, apnea events, breathing obstructions, choking, talking, coughing, etc. The respiration processor 314 is further configured to determine a confidence value, or quality value, associated with each physiological parameter or condition calculation. For example, for each sample of time for which the respiration processor 314 calculates a patient's respiration rate, the respiration processor 314 will also determine a confidence value (or quality value) associated with such calculation. Both the calculated physiological parameter value and the confidence associated with such calculation are displayed on a display 316.
Displaying both calculated parameters and confidence values advantageously helps a clinician to exercise her own clinical judgment in evaluating the patient's physiological condition. For example, instead of merely showing “error” or “no available signal” during physiological events that affect respiration detection, the physiological monitor 304 can provide the clinician with its best estimation of the physiological parameter while indicating that some other event has occurred that impacts the monitor's 304 confidence in its own calculations.
In addition, as data passes through the monitor 304, the monitor's various processing modules can appropriately process the data based upon the confidence level associated with each data point. For example, if data is identified as having a low confidence value, the monitor 304 can cause that data to have less or no influence over a physiological parameter calculation.
Identifying data quality can also advantageously allow the monitor 304 to process a continuous stream of data. For example, instead of stopping and starting data flow, or skipping “bad data” samples, the monitor 304 can continuously maintain and process the input data stream. This feature can allow implementation of much more robust, efficient, and less complex processing systems. For example, a finite infinite response filter (FIR filter) (or other filter) can break down, and large data portions may be lost, if it is used to process discontinuous or otherwise erroneous data. Alternatively, providing a data confidence or quality flag allows a processor employing an FIR filter to take further action avoid such problems. For example, in one embodiment, a low confidence or quality flag can cause a processor to substitute a measured data point value with an interpolated value falling between the two closest high confidence data points surrounding the measured data point.
The mixer 400 obtains high and low gain data from the data collection processor 312. Because the high and low gain channels of the acoustic sensor 302 can have known, fixed values, the mixer 400 is able to determine when the high gain channel 306 will clip. If data obtained from the high gain channel 306 exceeds a clipping threshold, the mixer can change the data input stream from the high gain channel to the low gain channel 308. The mixer 400 effectively optimizes, in certain embodiments, the two incoming data signals to generate a working output signal for further processing. In certain embodiments, the mixer 400 generates an optimized working output signal having a desired dynamic range by avoiding use of clipped (e.g., pre-amplifier saturated) data points.
Although not shown, a compression module can also be provided as an output from the mixer. The compression module can compress, down sample, and/or decimate the working output signal to produce a reduced bit-rate acoustic signal. The compression module can provide this reduced bit-rate acoustic signal to a database for data storage or for later analysis. In addition, the compression module can transmit the reduced bit-rate acoustic signal over a network to a remote device, such as a computer, cell phone, PDA, or the like. Supplying a reduced bit-rate acoustic signal can enable real time streaming of the acoustic signal over the network.
One embodiment of a method 420 of generating a working output signal is illustrated in
At block 426, the method 420 selects the high gain channel sample. At block 428, the method 420 sets a “valid” flag to “on.” The “valid” flag is one form of confidence or signal quality indicator, discussed above. Setting the “valid” flag to “on” indicates that the associated data sample may be a valid clinical data sample (for example, the measured value did not exceed a predetermined signal clipping threshold). The method 420 proceeds to block 430, where the method 420 stores both the selected sample and the flag values. The method 420 returns to block 422, where the next pair of samples is obtained from the high and low gain channels.
If at block 424 the method 420 determines that the high gain channel sample amplitude exceeds a high gain clipping threshold, the method 420 proceeds to block 432. At block 432, the method 420 selects the low gain channel sample. At block 434, the method 420 determines whether the low gain channel sample exceeds a low gain clipping threshold. If not, the method 420 proceeds to block 428, as described above.
If the method 420 determines that the low gain channel sample amplitude does exceed a low gain clipping threshold, the method proceeds to block 436. At block 436, the method 420 sets the “valid” flag “to “off.” Setting the “valid” flag to “off” indicates that the data sample may not be a valid clinical data sample. The method 420 then proceeds to block 430, as described above. The stored values (referred to as the “working” and “valid” signals in
The envelope processor 450 receives the working and valid signals from the mixer 400, discussed above. The envelope processor 450 processes these signals to generate a time domain envelope signal, a time domain valid signal, a noise floor, a frequency domain envelope signal, and a frequency domain valid signal. The exceptions processor 452 receives the working signal from the mixer 400 and the noise floor signal from the envelope processor 450 to generate a spectral envelope signal, a probe-off signal, and an interference signal. The time domain processor 454 and frequency domain processor 458 are described in further detail with respect to
By analyzing a working signal in both the time and frequency domains, in certain embodiments, the acoustic respiratory monitoring system 300 provides substantial, clinically significant advantages. To improve accuracy, the acoustic respiratory monitoring system 300 can seek to remove noise content from measured or sensed acoustic signals. However, noise can arise from multiple sources, and simple, single stage, or single engine processing techniques often provide inadequate results. For example, some noise occurs as a spike in signal amplitude. A slamming door, cough, or alarm could result in noise spike in an acoustic sensor's signal amplitude.
Other noise occurs in a more continuous nature. Such noise may not cause the sensor signal to spike in amplitude. For example, the low-frequency humming of a motor, light ballast, speech, or other vibration, could result in such continuous, relatively constant frequency noise signals. A time domain processor can be configured to effectively and efficiently remove amplitude-related noise content, while a frequency domain processor can be configured to effectively and efficiently remove frequency-related noise content. Employing both time and frequency processors can yield even further improved results.
In one embodiment, the spectral envelope processor 458 generates a spectrogram of the working signal. For example, each data point in the spectrogram signal can correspond to the highest frequency present in the working signal at that data point. Each data point in the working signal can correspond to the amplitude of the signal measured by the sensor 302 at a particular point in time. The spectral envelope provides the highest frequency present in the working signal at the same particular point in time.
The probe-off processor 460 determines whether the acoustic sensor 302 is properly attached to a measurement site on a patient. For example, if the working signal amplitude is below a certain threshold, the probe-off processor 460 determines that the acoustic sensor 302 is not properly attached to the patient's skin.
The interference processor 462 indicates whether an interference event has occurred. For example, the interference processor 462 indicates whether a noise event or disruption has been detected. Such events include can be identified, for example, when a loud instrument or device (e.g., a pump, generator, fan, ringing telephone, overhead page, television set, radio) has been turned-on or activated near the medical patient and/or whether the patient herself has generated an interfering, non-clinically relevant acoustical signal (e.g., sneezing, coughing, talking, humming, etc.).
The time domain processor 454 includes one or more envelope generators. For example, the time domain processor 454 can include one or more of a demodulation and decimation processor 488, a smoothing processor 490, and/or any other envelope generator (e.g., a Hilbert transformation processor, a power method envelope processor, etc.). The envelope processor 484 can also include a median filter 492. In one embodiment, the demodulation and decimation processor 488 includes the median filter 492.
In one embodiment, the demodulation and decimation processor 488 squares the input data, multiplies it by a factor of two, sends it through a filter (such as a low pass filter, a finite impulse response (FIR) filter, or an infinite impulse response (IIR) filter), buffers the output, provides the buffered output to a median filter 492, and then takes the square root, to derive an envelope signal. The median filter 492 picks out only the middle value of sorted, buffered data. For example, the median filter 492 first sorts the data and then selects the middle value. In one embodiment, the demodulation and decimation processor 488 buffers seven data points (or some other number of points) that are output from an FIR filter (as discussed above). The median filter 492 sorts the data (either high to low, or low to high), and then selects the value of the fourth data point (e.g., the middle of the seven data points) as its output value.
As subsequent data is analyzed by the demodulation and decimation processor 488, the buffered data is shifted by one sample, and the median filter 492 again selects the middle value of the sorted, buffered data. The median filter 492 is sometimes referred to as a running median filter.
The smoothing processor 490 employs another technique to derive a time domain envelope signal. For example, in one embodiment, the smoothing processor 490 processes buffered input data by determining a standard deviation, multiplying the output by three, squaring the output, and then sending the squared output to a filter, such as a low pass filter, FIR filter, or IIR filter.
The noise floor processor 486 determines the noise floor of its input signal. For example, the noise floor processor 486 can be configured to select a value below which or above which the input signal will be considered to be merely noise, or to have a substantial noise content.
In one embodiment, the frequency domain envelope processor 500 transforms the working signal into the frequency domain by utilizing a Fourier transform (e.g., fast Fourier transform (FFT), discrete Fourier transform (DFT), etc.). The frequency domain processor 456 can then identify an envelope of the output of the Fourier transform. For example, the frequency domain processor 456 can square an absolute value of the Fourier transform output. In some embodiments, the frequency domain processor 456 further processes the output with sub matrix, mean, log, and gain operations. Additionally, in some embodiments, the output is buffered and provided to a median filter 502, which can operate under the same principles as the median filter 492 described above with respect to
Although not shown, in certain embodiments, the frequency domain processor 456 can also calculate spectral information, such as a power spectrum, spectral density, power spectral density, or the like. In one embodiment, the spectral information X can be calculated as follows:
X=20 log(FFT(x)) (1)
where x in equation (1) represents the working signal input to the envelope processor 450 (or a processed form of the working signal). The spectral information can be calculated for each block or frame of samples received by the envelope processor 450. The spectral information can be calculated using other techniques than those described herein. For example, the log(FFT(x)) may be multiplied by 10 instead of 20, or the power spectral density may be calculated from the Fourier transform of the autocorrelation of the input signal, or the like.
The spectral information from multiple blocks or frames of samples can be combined to form a representation of changes in the spectral information over time. If this combined spectral information were output on a display, the combined spectral information could be considered a spectrogram, a waterfall diagram, or the like. An example of such a spectrogram is described below with respect to
In the depicted embodiment, the back end processor 404 receives a time domain (TD) envelope, a time domain (TD) valid signal, a frequency domain (FD) envelope, a frequency domain (FD) valid signal, a spectral envelope, noise floor information, and interference information. These inputs can be generated using any of the systems and processes described above. Not all of these inputs need be used or received by the back end processor 404 in certain implementations.
The back end processor 404 includes a time domain respiratory rate (TD RR) processor 910, the frequency domain respiratory rate (FD RR) processor 920, and an arbitrator 930. The TD RR processor 910 can use time domain techniques to derive respiratory rate values from various ones of the inputs received by the back end processor 404. The TD RR processor 910 can also calculate confidence values reflecting confidence in the calculated respiratory rate values. The FD RR processor 920 can use frequency domain techniques to derive respiratory rate values from various ones of the inputs received by the back end processor 404. The FD RR processor 920 can also calculate confidence values reflecting confidence in the calculated respiratory rate values. In some embodiments, only time domain techniques or only frequency domain techniques are used by the back end processor 404 to calculate respiratory rate.
The TD RR processor 910 and the FD RR processor 920 can provide respiratory rate outputs and confidence values to the arbitrator 930. In certain embodiments, the arbitrator 930 can evaluate the time domain and frequency domain respiratory rate calculations as well as the confidence values to select a respiratory rate value to output. Based on the confidence calculations, the arbitrator 930 can output the respiratory rate values derived from the time domain or from the frequency domain. The arbitrator 930 can also combine the respiratory rate values derived from the different domains, for example, by averaging the values together.
For ease of illustration, this specification describes the respiration processor 314 as having time domain and frequency domain processors or engines. However, in other embodiments, the respiration processor 314 can include only a time domain engine, only a frequency domain engine, or additional engines in combination with either of the time domain and frequency domain engines or with both. The arbitrator 930 can calculate an overall respiratory rate based on the outputs of any of the engines, including a combination of the engines. The arbitrator 930 can weight, select, or otherwise choose outputs from the different engines. The weightings for each engine can be learned and adapted (e.g., using an adaptive algorithm) over time. Other configurations are possible.
One example of an additional engine that can calculate respiratory rate is a wavelet-based engine, which can be used to perform both time and frequency domain analysis. In one embodiment, the respiration processor 314 includes the wavelet analysis features described in U.S. application Ser. No. 11/547,570, filed Jun. 19, 2007, titled “Non-invasive Monitoring of Respiratory Rate, Heart Rate and Apnea,” the disclosure of which is hereby incorporated by reference in its entirety.
Another example of an engine that can be used to calculate respiratory rate is an engine based on a Kalman filter. The Kalman filter can be used to predict a state of a system, such as the human body, based on state variables. The state of the human body system can depend on certain state parameters, such as hemodynamic parameters (e.g., heart rate, oxygen saturation, respiratory rate, blood pressure, and the like). A Kalman filter model can be developed that interrelates these parameters. As part of this model, one or more measurement equations can be established for measuring the various state parameters, including respiratory rate.
The arbitrator 930 can also calculate a freshness or relevance of the respiratory rate measurement. In some situations, the confidence output by the arbitrator 930 may be low, and the corresponding respiratory rate output value may be invalid or corrupted. One option when this happens is to discard the invalid or low quality respiratory rate value and not display a new respiratory rate measurement until a valid or higher quality value is obtained. However, not displaying a respiratory rate value (or showing zero) can confuse a clinician if the patient is still breathing. Likewise, cycling between zero and a valid respiratory rate value can be annoying or confusing for a clinician.
Thus, instead of displaying no (or zero) value in low quality signal conditions, the arbitrator 930 can continue to output the previous respiratory rate measurement for a certain amount of time. The arbitrator 930 can include a counter, timer, or the like that increments as soon as a low or invalid signal condition is detected. When the arbitrator 930 determines that a certain amount of time has elapsed, the arbitrator 930 can output a zero or no respiratory rate value. Conversely, if while the arbitrator 930 is incrementing the counter a valid or higher quality respiratory rate measurement is produced, the arbitrator 930 can reset the counter.
The amount of time elapsed before the arbitrator 930 outputs a zero or no respiratory rate value can be user-configurable. The arbitrator 930 can output the elapsed time that the respiratory rate measurement has had low or no confidence. The arbitrator 930 could also (or instead) output an indicator, such as a light, changing bar, number, an audible alarm, and/or the like that is output when the arbitrator 930 is incrementing the counter. The indicator can be deactivated once valid or higher confidence respiratory rate values are calculated.
By way of overview, the TD RR processor 1000 can determine respiratory rate by identifying energy in the time domain that has possible meaning. Meaningful energy can include peaks in the TD envelope that correspond to inspiration and/or expiration. The TD RR processor 1000 can disqualify energy that does not have meaning, including energy due to noise (e.g., coughing, sneezing, talking, chewing, ambient noise from the environment, etc.). From the energy that has meaning, the TD RR processor 1000 can calculate respiratory rate. Moreover, the TD RR processor 1000 can calculate one or more confidence values reflecting confidence in the calculated respiratory rate.
In the depicted embodiment, the TD RR processor 1000 includes a variable filtering module 1010, an automatic tagging module 1020, and an RR estimation module 1030. Each of these modules can be implemented in hardware and/or software. Each of these modules can operate on blocks or frames of samples in certain implementations (see, e.g.,
The variable filtering module 1010 receives a TD envelope, such as the TD envelope described above. The variable filtering module 1010 can apply one or more filters to the TD envelope to smooth the TD envelope. The one or more filters can include a low pass filter. Smoothing the TD envelope can reduce noise in the TD envelope. In certain embodiments, the variable filtering module 1010 can change the cutoff frequency or frequencies of the one or more filters based at least in part on previously calculated RR values. Using a previously calculated respiratory rate value to determine a cut off frequency of a smoothing filter can reduce errors that can occur from over-smoothing or under-smoothing the TD envelope. Over smoothing can occur if the new respiratory rate value is relatively high for a given lower cutoff frequency, and under smoothing can occur if the new respiratory rate value is relatively low for a given higher cutoff frequency.
In the depicted embodiment, the variable filtering module 1010 receives a previous respiratory rate value (RR_old) from the RR estimation module 1030 via a delay block 1040. In one embodiment, if the previous respiratory rate value is above a certain threshold, the cutoff frequency for the smoothing filter is increased to a certain value. If the previous respiratory rate value is below a certain rate, then the cutoff frequency for the smoothing filter can be decreased to a certain value. The cut off frequency can also be adjusted on a sliding scale corresponding to the previous respiratory rate value. In one embodiment, the cut off frequency can range from about 1 Hz to about 3 Hz. This range can be varied considerably in certain embodiments.
The variable filtering module 1010 can also create a difference envelope by subtracting the TD envelope from the filtered envelope (or vice versa). The difference envelope can be used in glitch detection and reduction, as will be described in greater detail below. The variable filtering module 1010 can provide the filtered and difference envelopes to the automatic tagging module 1020.
In certain embodiments, the automatic tagging module 1020 identifies peaks in the filtered TD envelope that correspond to inspiration and/or expiration. Each peak can be referred to as a tag. The automatic tagging module 1020 can determine confidence and the identified tags based at least in part on a received TD and/or FD valid signal, a spectral envelope signal, and/or a noise floor signal. These signals and values are described in part above with respect to
The automatic tagging module 1020 can output the tags and confidence values corresponding to the tags to the RR estimation module 1030. The RR estimation module 1030 can estimate respiratory rate from the identified tags. For example, the RR estimation module 1030 can calculate time periods between pairs of tags within a given processing frame to derive a respiratory rate value for each pair of tags. In one embodiment, the RR estimation module 1030 calculates respiratory rate for every first and third peak so as to calculate respiration from inspiration to inspiration peak and/or from expiration to expiration peak. The respiratory rate value can be derived by multiplying the reciprocal of the time period between two peaks by 60 (seconds per minute) to achieve breaths per minute. The RR estimation module 1030 can average the respiratory rate values from the various tag pairs within the processing frame. This average can be a weighted average (see
The automatic tagging module 1100 includes a tag detection module 1110, a glitch removal module 1120, a tags rejection module 1130, and a tags confidence estimation module 1140. Each of these modules can be implemented in hardware and/or software. Each of these modules operate on blocks or frames of samples in certain implementations.
The tag detection module 1110 receives the filtered (TD) envelope, a valid signal, and the noise floor signal. The tag detection module 1110 can make a preliminary detection of peaks and/or valleys in the filtered envelope. The tag detection module 1110 can use the noise floor signal to determine which peaks are above the noise floor. The tag detection module 1110 can include an adaptive threshold, for instance, for estimating which peaks should be considered tags based at least in part on the noise floor level. Thus, peaks occurring below the noise floor may not be considered to be tags that represent inspiration or expiration. In addition, the tag detection module 1110 can have an upper threshold based at least in part on a root mean square (RMS) value of the filtered envelope. Peaks above the upper threshold may not be considered to be tags because they may be due to noise such as talking or the like.
The tag detection module 1110 can output preliminary tags (referred to as tags_1 in the FIGURE) to the glitch removal module 1120. The glitch removal module 1120 can compare the identified tags with the difference envelope described above with respect to
The glitch removal module 1120 can provide the tags to the tags rejection module 1130. The tags rejection module 1130 can use any of a variety of techniques to remove tags that possibly do not correspond to inspiration or expiration sounds of a patient. For instance, the tags rejection module 1130 could reject a tag if it is too close to another tag. Tags that are too close together could result in a respiratory rate that is too high and therefore not physiologically possible. In certain embodiments, the smaller of the two peaks is rejected, although this may not always be the case. The closeness constraint could be relaxed or not used entirely for certain patients, such as neonates, who may have a higher respiratory rate.
Another technique that could be used by the tags rejection module 1130 is to find peaks that are related. Peaks that are related can include peaks that do not have a clear separation from one another. For example, a valley separating two peaks could be relatively shallow compared to valleys surrounding the peaks. In certain embodiments, if the valley between the peaks falls below half the amplitude of one or both of the peaks, the peaks could be considered to be separate peaks or tags. Otherwise, the peaks could be considered to be one tag (e.g., corresponding to two intakes or exhales of air in rapid succession).
The tags rejection module 1130 could also analyze tags that appear at the beginning and/or end of a block of samples or frame. The tags rejection module 1130 could select to reject one of these first or last peaks based at least in part on how much of the peak is included in the frame. For instance, a peak that is sloping downward toward the beginning or end of the frame could be considered a tag for that frame; otherwise, the tag might be rejected.
Another technique that can be used by the tags rejection module 1130 is to identify and remove isolated peaks. Since breathing sounds tend to include an inspiration peak followed by an expiration peak, an isolated peak might not refer to a breathing sound. Therefore, the tags rejection module 1130 could remove any such peaks. The tags rejection module 1130 could also remove narrow peaks, which may not realistically correspond to a breathing sound.
Moreover, in certain embodiments, the tags rejection module 1130 can perform parametric rejection of peaks. The tags rejection module 1130 can, for example, determine statistical parameters related to the peaks within a block or frame, such as standard deviation, mean, variance, peaks duration, peak amplitude, and so forth. If the standard deviation or mean the value of the peak or peaks is much different from that of the previous block or frame, one or more of the peaks may be rejected from that block. Similarly, if the duration and/or amplitude of the peaks differ substantially from the duration and/or amplitude of peaks in a previous block or frame, those peaks might also be rejected.
The tags rejection module 1130 can provide the refined tags (referred to as tags_3 in the FIGURE) to the tags confidence estimation module 1140. The confidence estimation module 1140 can also receive the spectral envelope calculated above and the noise floor signal. The confidence estimation module 1140 can use a combination of the tags, the spectral envelope, and/or the noise floor to determine a confidence value or values in the tags. The confidence estimation module 1140 can output the tags and the confidence value.
In certain embodiments, the confidence estimation module 1140 can determine confidence in the tags received from the tags rejection module 1130. The confidence estimation module 1140 can use one or more different techniques to determine confidence in the tags. For instance, a confidence estimation module 1140 can analyze power or energy of the tags in the time domain. The confidence estimation module 1140 can also analyze the distribution of frequency components corresponding to the tags in the frequency domain. The confidence estimation module 1140 can use either of these two techniques or both together.
As described above, respiratory rate can be calculated for each first and third tag (e.g., inspiration peak to inspiration peak or expiration peak to expiration peak). However, for ease of illustration, time periods in
In the plot 1151 and 1152, peaks or tags 1154a, 1154b, 1154c, and 1154d are shown along a timeline. In the plot 1151, a time period 1170 between the first two peaks 1154a and 1154b is 20 seconds. A time period 1172 between the peaks 1154b and 1154c is 5 seconds, and a time period 1174 between peaks 1154c and 1154d is also 5 seconds. Two processing windows (or frames) 1162, 1164 are shown. Processing windows can be slid over time, causing older peaks to fall out of the window and newer peaks to enter. Thus, the second window 1164 occurs after the first window 1162.
If the RR estimation module 1030 were to compute a respiratory rate value for each window 1162, 1164 using simple averaging, the respiratory rate values for each window 1162, 1164 would differ substantially in this example. The average period for the first window 1162 would be equal to (20 seconds+5 seconds+5 seconds)/3, resulting in an average 10 second period. The average respiratory rate value for this window 1162 would then be 1/10*60 seconds, or 6 breaths per minute (BPM). The average time period between peaks for the second window 1164 is (5 seconds+5 seconds)/2=5 seconds, resulting in an average respiratory rate of 12 BPM. This respiratory rate value is twice the respiratory rate value calculated for the first time window 1162, resulting in a significant jump or discontinuity between respiratory rate values. This jump results from the respiratory rate value from the oldest tag 1154a being dropped from the second window 1164.
To reduce or prevent these jumps in average respiratory rate values between windows, a weighted average can be computed instead of a simple average. This weighted average is illustrated in the plot 1152 of
The weights for pairs of peaks remaining in the window 1164 can simply be 1. Thus, the average respiratory rate in BPM for a window can be computed as follows:
where n represents the number of tag pairs in the window, Ti represents the time period of the ith tag pair, and vi represents the ith weight, which may be 1 for all weights except v1, which is equal to v′/v.
In the plot 1153 of
A processing window 1166 is shown. This window 1166 does not include the two initial peaks 1184a and 1184b. Partial periods v1′ and v2′ can be calculated as shown. The partial period v1′ can be calculated as the time difference between the start of the window 1166 and a feature of the next alternate peak (1184c). Similarly, the partial period v1′ can be calculated as the time difference between the start of the window 1166 and a feature of the next alternate peak (1184d). The weights of contributions of the periods from the earlier peaks 1184a and 1184b can therefore be v1′/v1 and v2′/v2, respectively.
Generally, weight v′/v can also be referred to as an occurrence value, reflecting an amount of occurrence that a particular peak has on a processing window. In one embodiment, the time domain respiratory processor 1000 can output an occurrence value for each tag in a processing window. The use of the occurrence value is described below with respect to
The time domain power analysis technique can be described in the context of
The noise floor signal received by the confidence estimation module 1140 is plotted as the line 1210. The line 1210 is a simplified representation of the noise floor. Other lines 1212, 1214, and 1216 are drawn on the plot 1200 to represent different regions 1220, 1222, and 1224 of the plot 1200. A peak 1204 of the tag 1202 falls within the region 1222. In the depicted embodiment, tags having peaks falling within this region 1222 are assigned 100% confidence.
If the peak 1204 were in the region 1220, the confidence assigned would be less than 100%. The confidence can drop off linearly, for example, from the line 1212 to the line 1210. Confidence can decrease as the peak is smaller because the peak would be close to the noise floor 1210. Peaks falling below the noise floor 1210 can be assigned 0% confidence.
Likewise, peaks that exceed a threshold represented by the line 1216 can also have zero confidence. These large peaks are more likely to represent talking or other noise, rather than respiration, and can therefore be assigned low confidence. From the line 1214 representing the end of the 100% confidence region, confidence can linearly decrease as peak amplitude increases to the line 1216.
The threshold represented by the lines 1210, 1212, 1214, and 1216 can be changed dynamically. For instance, the thresholds represented by the lines 1210 and 1212 can be changed based on a changing noise floor. In certain embodiments, however, the upper thresholds represented by the lines 1214, 1216 are not changed.
It should be understood, in certain embodiments, that the plot 1200 need not be generated to determine confidence in the respiratory rate values. Rather, the plot 1200 is illustrated herein to depict how one or more dynamic thresholds can be used in the time domain to determine respiratory rate confidence.
As mentioned above, the confidence estimation module 1140 can also analyze the distribution of frequency components corresponding to the tags in the frequency domain. The confidence estimation module 1140 can analyze the frequency components using the spectral envelope described above. A spectrogram can be plotted to illustrate how confidence can be calculated from the spectral envelope, as shown in
In certain embodiments, respiration sounds can approximately correspond to white noise. However, respiration sounds are generally distributed in the frequency range of about 0 Hz to about 2 kHz. More particularly, in certain embodiments, respiration sounds can be distributed in the frequency range of about 200 Hz to about 1.2 kHz. Below about 200 Hz, sounds are usually hard sounds. Above about 1.2 kHz, sounds include moans, size, speech (speech also has lower frequency components), and the like.
Thus, in a first region 1322 (denoted by lines 1312 and 1314), 100% confidence is assigned if a peak falls within this region 1322. Peaks falling outside of this region 1322 can have a confidence that drops off linearly to 0% confidence, as shown in the FIGURE.
In certain embodiments, this confidence value determined from the spectrogram 1300 can be further refined by the density of the spectrogram at each peak. If a peak at a given point in time represents narrowband or periodic noise (e.g., a pure tone), it may have been derived from a spectrum having fewer frequency components than a respiration spectrum. The frequency spectrum corresponding to the time where the peak occurs can therefore be considered to be less dense. In contrast, if a peak at a given point in time comes from a broader spectrum, that peak can be considered to be denser. Spectral density is schematically represented by line 1330, with more tick marks on the line representing greater density.
If the density is low, the peak can likely represent narrowband noise or periodic noise. An example of narrowband noise can include an alarm from a medical instrument. Examples of periodic noise can come from medical instrumentation that emits periodic noise, such as CPAP machine cycles, noise from motors, and the like. Periodic noise can also result from speech, closing doors, motor vehicles (e.g., in the hospital parking lot), and the like. If the density is higher, the peak more likely represents a respiration sound because respiration can be relatively more broadband than narrowband or periodic noise. As a relatively broadband signal, respiration can include more spectral components than a narrowband signal. Thus, respiration signals can be more spectrally dense than narrowband noise signals.
In fact, in some instances, respiration can resemble white noise over a certain bandwidth. Somewhat paradoxically, the broadband sound (respiration) is the signal that is to be detected, rather than the narrowband/periodic sound, which can be the noise. This detection problem contrasts with typical detection problems where a narrowband signal of interest is to be detected from broadband noise.
Thus, in certain embodiments, the calculated density of spectral information corresponding to a time when a peak can be used at least in part to determine confidence values. In brief, the denser a signal is, the more confident the respiration processor can be that the signal contains respiration. Conversely, the less dense the signal, the less confident the respiration processor can be that the signal includes respiration. More detailed features for computing and analyzing spectral density are described below with respect to
Referring again to
In the depicted embodiment, spectral information is provided to the density calculator 1382. This spectral information was described above with respect to
Spectral density as calculated by the density calculator 1382 can be further understood in the context of example waveforms 1319 depicted in
The spectrogram 1317 is plotted with respect to frequency over time. At each slice in time (represented on the “x” axis), a magnitude frequency response is plotted (represented on the “y” axis). This magnitude frequency response can be obtained, as described above, from an FFT performed on a block or frame of input samples. In the depicted example spectrogram 1317, the magnitude of a particular frequency is illustrated by the brightness or intensity of the points (e.g., pixels) in the spectrogram. Thus, brighter points tend to represent higher frequency magnitudes while dimmer pixels tend to represent lower frequency magnitudes.
The spectrogram 1317 differs from the spectrogram 1300 shown in
Some features of the spectrogram 1317 include respiration portions 1330, speech portions 1340, narrowband portions 1342, and ambient noise portions 1350. The respiration portions 1330 in the depicted embodiment extend through most of all of the frequency spectrum (e.g., at a given point in time), illustrating how respiration can be broadband sound. In the depicted embodiment, the energy of the respiration portions 1330 is greatest in the lower frequencies (e.g., below about 1 kHz), although this may not always be the case. Because respiration energy can sometimes be greatest in the lower frequencies, the confidence estimation module 1340 of
The speech portions 1340 of the example spectrogram 1317 reflect an example pattern of speech. As speech can include periodic or narrowband signals, narrowband portions 1342 are illustrated in the speech portion 1340. These narrowband portions 1342 appear as striations on the spectrogram 1317. At any one slice in time, the frequency response at the speech portions 1340 of the spectrogram 1317 are less dense than the example respiration portions 1330. The confidence estimation module 1340 of
The ambient noise portions 1350 reflect low-level background noise from the environment (e.g., the environment around a patient). For example, the ambient noise can include white noise. Because this ambient noise has signal energy, it can adversely affect a density calculation by inflating the calculated density. Thus, in certain embodiments, the density calculator 1382 of
An example process 1390 for calculating spectral density that takes into account the ambient noise 1350 is illustrated in
Over time, the spectral bias can be smoothed or averaged, for example, by applying a weighted average or the like. Any smoothing filter can be used to average the spectral bias. For example, a first-order IIR filter can be used to smooth the spectral bias. In one embodiment, the ambient noise energy is weighted such that the spectral bias decreases slowly but increases quickly. By decreasing slowly, the spectral bias can be used to exclude relatively louder ambient noises. By increasing quickly, the spectral bias can be used to assist with detection of shallow breathing signals.
At block 1393, the energy of each frequency bin in the spectral information is determined. As mentioned above with respect to
At decision block 1394, it is determine for each bin, whether the energy of the bin is greater than the spectral bias. If so, then a counter is incremented at block 1395. Otherwise, the counter is not incremented, and the process 1390 proceeds to decision block 1396. Incrementing the counter for a bin can reflect that the bin is spectrally dense, or in other words, that the bin should be counted toward the spectral density calculation. Said another way, in certain embodiments, when the energy of a bin exceeds the ambient noise level of that bin, the bin is counted toward the spectral density.
At decision block 1396, it is further determined whether any additional bins remain to be processed. If so, the process 1390 loops back to block 1394. Otherwise, spectral density is calculated at block 1397, for example, by dividing the counter value by the total number of bins considered. In effect, the process 1390 can therefore determine the ratio (or percentage) of bins that have a spectral density above the spectral bias.
The spectral density can be determined using other techniques or algorithms. For example, spectral density can be computed by summing the energy levels (obtained at block 1393) for the bins. Further, in some embodiments, this sum can be divided by the total number of bins considered to arrive at a mean energy value. This mean energy value can be the spectral density. Many other techniques can be used to calculate the spectral density, as will be apparent from this disclosure.
Referring again to
Also shown in the graph 1321 is a one-dimensional spectrogram 1360, which includes the features of the spectrogram 1300 described above with respect to
Referring again to
An example illustrating the pattern matching techniques of the matched filter 1384 is shown in
In the example embodiment shown, the density portions 1371 do not appear similar to the sinusoidal patterns 1373. Thus, the output of the matched filter 1384 would be relatively small, indicating that these density portions 1371 likely do not reflect the presence of respiration. This conclusion makes sense, given that the density portions 1371 analyzed fall within the breathing portion 1340 of the spectrogram 1317. Conversely, if the density portions 1371 more closely matched the sinusoidal patterns 1373, the output of the matched filter 1384 would be relatively larger, reflecting the possible presence of respiration.
Referring again to
The matched filter 1384 can initially detect the patient's baseline template using the sinusoidal template in one embodiment. The matched filter 1384 can also adjust the patient's baseline template over time as the patient's breathing changes. For instance, the matched filter 1384 can average a patient's density shapes for each detected respiration to derive an average baseline template.
The matched filter 1384 provides a filtered output. In one embodiment, the matched filter 1384 provides a higher output if the density data matches the template than if the density data does not match the template. The filtered output is provided to the confidence module 1386. The confidence module 1386 can receive the filtered output, the spectral envelope (see
In certain embodiments, the confidence module 1386 calculates a confidence reflecting whether the identified tags represent breaths. The confidence module 1386 can calculate this confidence using the features described above with respect to
An example of such a density threshold 1372 is shown in
The confidence module 1386 can further base confidence at least in part on the degree to which the filtered output from the matched filter 1384 exceeds a threshold. Thus, the confidence module 1386 can use both the density data and the matched filter 1384 output together to determine confidence. In some implementations, the confidence module 1386 can use one or both of density and matched filter 1384 output to determine confidence. The confidence module 1386 can also use other signal features to calculate confidence, some of which are discussed elsewhere herein.
In certain embodiments, the user-adjustable sensitivity input into the confidence module 1386 can advantageously adjust one or more of the thresholds used by the confidence module 1386. The user-adjustable sensitivity can be used to select between focusing on detecting non-respiration events (such as respiratory pauses, apnea, and the like) and focusing on detecting respiration events. In some care scenarios, it can be more important to a clinician to determine whether a patient is breathing than what the patient's precise respiratory rate is. Thus, the user-adjustable sensitivity can be used to select this preference. For example, in one embodiment, the user-adjustable sensitivity can be controlled by a clinician via a user interface on a patient monitor. A display button or other user interface control (such as a hardware button or switch) can allow the clinician to select between detecting respiratory pauses, apnea, or the like and more precise detection of respiratory rate.
If the clinician selects detection of respiratory pauses or the like, the user-adjustable sensitivity control can be adjusted to cause the density threshold 1372 to be set higher than if the clinician selects more accurate respiratory rate detection. Thus, the confidence module 1386 can intentionally under-read respiratory rate to more aggressively detect lack of breathing. By under-reading respiratory rate, the confidence module 1386 can ultimately cause more alarms to be triggered, enabling clinicians to respond to patients who are not breathing. Thus, scenarios can be avoided or reduced where clinicians are unaware of a patient's cessation of breathing, allowing clinicians to save more lives.
The user-adjustable sensitivity can be provided to the confidence module 1386 from the patient monitor. The user-adjustable sensitivity can be used by the confidence module 1386 to adjust the density threshold 1372 (see
Another advantageous feature that can be provided in certain embodiments is to use manual tags generated by a clinician to train the confidence estimation module 1340. Example indicators 1364 of manual tags are depicted in
Referring to
Other centroids can have higher values, such as the centroid 1399b in the spectrum 1398b (where energy is concentrated in high frequencies) and the centroid 1399c of the spectrum 1398c (where energy is distributed evenly across the spectrum 1398c). Thus, the higher the centroid 1399, the less likely the spectrum 1399 represents respiration, and vice versa.
In one embodiment, the tags confidence estimation module 1140 can analyze the centroid of a spectrum for a given point in time, in addition to or instead of analyzing spectral density, and spectral envelope peaks. The lower the centroid, the more confident the tags confidence estimation module 1140 can be that tags correspond to respiration, and vice versa. Similarly, the tags confidence estimation module 1140 can indicate that a respiration pause is more likely if the centroid is relatively higher than during respiration periods.
Another concept that can be useful in distinguishing respiration from respiratory pauses and background noise is entropy. Entropy, or Shannon entropy, can generally represent the order (or disorder) of a signal. A signal that is more ordered, such as speech (which tends to have well-ordered harmonics), can have a higher entropy value. A signal that is less ordered, such as respiration, can have a lower entropy value. Thus, the tags confidence estimation module 1140 can calculate the entropy of an acoustic signal (e.g., according to processing windows) and can compare the entropy of the acoustic signal to some threshold to estimate whether the signal represents background noise/respiratory pauses or respiration.
In other embodiments, trends of centroids and entropy values are analyzed instead of thresholds. Further, entropy and centroids can be analyzed together to estimate confidence/respiratory pauses, and the like. In addition, entropy, centroids, spectral density, and spectral envelope peaks can be used together to estimate confidence/respiratory pauses, and the like. For instance, each of these quantities can be normalized on a scale (such as from 0 to 1) and multiplied together to produce a probability of respiration. If the multiplied value is close to 1 on a scale of 0 to 1, the probability that a respiration is detected can be close to 1, and vice versa. Some subset of the parameters entropy, centroids, spectral density, and spectral envelope peaks can be used to analyze confidence and/or respiratory pauses in different implementations. Other parameters may also be used, including other statistical parameters.
Referring again to
The RR estimation module 1030 can determine the overall TD RR confidence value for a given block or frame by averaging confidence values for each peak or tag within the frame. The RR estimation module 1030 can therefore output an overall TD RR confidence value.
The FD RR calculation process 1400 can analyze an FD envelope obtained above. The FD RR calculation process 1400 will be described in the context of the example frequency envelopes or spectrums 1510, 1520 shown in
At block 1402, peaks that do not have harmonics are removed from the frequency envelope. Referring to
Referring again to
Thus, in
Referring again to
Although not shown, in some cases, although the first peak has harmonics, the maximum peak may still be selected as corresponding to respiratory rate based on historical past respiratory rate values. For instance, if the respiratory rate value calculated by the first peak is much different from the previously calculated value, the respiratory rate value for the second peak may be selected if it is closer to the historical value. In addition, although example spectrums have been shown in
Referring again to
In some embodiments, if the amplitude of the acoustic signal for a given frame or processing window is small (e.g., below a threshold), the frequency domain processor can zero out or otherwise perform no analysis. Similarly, if the respiratory rate calculated by the frequency domain processor is very high (e.g., above a threshold where patients typically cannot breathe so fast), the frequency domain processor can zero out the calculated respiratory rate value. Alternatively, in either the case of low signal level or high calculated respiratory rate, the frequency domain processor can calculate low or zero confidence instead of zeroing out the frequency domain respiratory rate value.
Advantageously, in certain embodiments, FD RR analysis can be simpler than TD RR analysis. However, using both in conjunction can reduce errors and provide more accurate confidence analysis. For instance, if the FD spectrum includes harmonic peaks that are substantially equal in value, it can be difficult to determine which corresponds to inspiration and which correspond to expiration. Thus, the FD RR processor 920 might calculate a respiratory rate that is double the actual respiratory rate. The RR calculated in the time domain, if half that rate, is likely to be more accurate. In certain embodiments, the arbitrator 930 described above arbitrates between the TD and FD engines to output a more accurate respiratory rate value.
The arbitrator 1600 includes a decision logic module 1610 and a post-processing module 1620. The decision logic module 1610 can receive the TD and FD RR and confidence values. The decision logic module 1610 can select RR and confidence values within a block or frame, whereas the post-processing module 1620 can determine an overall RR and an overall confidence value for a period of time. As frames can overlap, the post-processing module can determine the overall RR and confidence values for several frames.
The post-processing module 1620 can output the RR value, the confidence value, and the elapsed time value discussed above for presentation to a user. The confidence value output by the post-processing module 1620 can be referred to as a respiratory signal quality (RSQ) value or indicator. However, any confidence value described herein could also be referred to as a respiratory signal quality (RSQ) value or indicator.
Several techniques of the decision logic module 1610 will now be described, some of which may be implemented in certain embodiments, while others are implemented in others. All techniques may also be implemented. It should also be noted that two TD RR values and possibly two confidence values can be output by the TD RR processor 910, as described above. Either of these TD RR values can be compared with the FD RR value or an average of the two can be compared with the FD RR value. Or, each can be compared with each other using the techniques described below, and then one can be selected and compared with the FD RR value.
In certain embodiments, the decision logic module 1610 can compare the TD and FD RR values within a frame to determine if they are close to each other. If they are close, the decision logic module 1610 could output either value. In one embodiment, the decision logic module 1610 outputs the value with the higher associated confidence value. If the values are not close, the decision logic module 1610 can output the RR value from the engine that is closest to a previous RR value.
If both TD and FD RR values are of high confidence but not close (within a delta), and neither is close to a previous value, then the decision logic module 1610 can output one of the values if it passes other checks. For instance, if the FD value is double the TD value (e.g., for reasons discussed above), the decision logic module 1610 could output the TD value instead.
In one embodiment, the decision logic module 1610 outputs a RR value only if either the TD or FD confidence is above a threshold. If both are below a threshold (which may differ for both), the decision logic module 1610 can output a zero RR value or “not a number” (NaN) type RR value.
The post-processing module 1620 can average or otherwise combine the FD and TD RR values from possibly overlapping frames based on a selected averaging time. The averaging time can be user selectable in some embodiments. For instance, if the averaging time is 30 seconds, the post-processing module 1620 can average the TD and/or FD values selected for overlapping frames falling within the 30 second period. The output of this averaging can be an overall RR value. In one embodiment, the post-processing module 1620 performs a weighted average in of the respective respiratory rate values. The post-processing module 1620 can, for instance, use the calculated confidence values as weights or to derive weights to be applied to the respiratory rate values.
The post-processing module 1620 can similarly average the TD and RR confidence values to obtain an overall confidence value. Various combinations can be used to obtain the overall confidence value. For example, the confidence values can be averaged (and possibly weighted) over several confidence values. Also, a number of nonzero points can be selected from a buffer of confidence values and divided by the total number of points in the buffer. For example, if a buffer has five total confidence measurements, and two of those are zero, the overall confidence value could be ⅗. Also, the overall confidence value could be a combination of the weighted average and the nonzero-based confidence calculation. Many other embodiments are possible.
An alternative embodiment to the arbitrator 1600 is illustrated in
In one embodiment, the time domain parameters include each respiratory rate value calculated during a given window, corresponding time stamps for the respiratory rate values, confidence values for each respiratory rate value, and an occurrence value for each respiratory rate value (see
The long frequency domain parameters can include the frequency domain respiratory rate and confidence value calculated for a given frame or processing window. Likewise, the long frequency domain parameters can also include time stamps for the respiratory rate values and optionally occurrence values (which may be 1). In contrast, the short frequency domain parameters can include multiple respiratory rate and corresponding confidence values in a given time window. These parameters are referred to as short because a shorter time window (within the main frame or processing window) is used to calculate multiple respiratory rate values.
An illustration of calculating the short frequency domain parameters is shown with respect to
In one embodiment, the time domain and frequency domain envelopes are calculated for the frame 1640, using the techniques described above. The long frequency domain parameters are thus derived from the frame 1640. The short frequency domain parameters are derived from frequency envelopes for each subframe 1650, 1660, and 1670. The frequency domain processor described above can calculate a separate respiratory rate and associated confidence value for each subframe 1650, 1660, and 1670, as well as associated time stamps and optionally occurrence values (which may be 1). These short frequency domain parameters can be used in decision logic of the arbitrator 1630 of
In certain embodiments, a logical module used to calculate the short frequency domain parameters can be considered a second frequency domain processor or engine. Thus, the respiration processor 314 of
Example features of the arbitrator 1630 can be explained in the context of
The points 1710 in the point cloud plot 1700 represent time domain respiratory rate values, long frequency domain respiratory rate values, and short frequency domain respiratory rate values, as indicated by the legend 1720. The time axis of the plot 1700 is divided into frames or processing windows 1730. In certain embodiments, possibly multiple time domain respiratory rate values can be calculated for each window 1730. A single long frequency domain respiratory rate value can be calculated in each window 1730, and multiple short frequency domain respiratory rate values can be calculated in each window 1730 (see
The point cloud plot 1700 reflects trends in the respiratory rate values over time. These trends can be analyzed to determine one or more measures of how accurate respiratory rate values are for each time domain and frequency domain processor. An analysis window 1740 can be used to analyze these trends and other statistical measurements. The analysis window 1740 can be the same as the current processing window 1730 or can cover multiple processing windows 1730.
Respiratory rate data from example analysis windows is shown in more detail in
Generally, the arbitrator 1730 of
Each curve can be assessed by the arbitrator 1630 to determine the quality of an engine's respiratory rate values. This quality can be analyzed to score the outputs of the different respiration engines. One measure of quality is the stability, or goodness-of-fit, of the curves 1740, 1760. In the plot 1730, the curve 1740 has a relatively large degree of error due to the wide dispersion of the points 1732. Thus, the stability of this curve 1740 is relatively low. In contrast, the points 1752 in the plot 1750 are less dispersed, and the stability of the curve 1760 is therefore higher. Stability can be calculated, for example, with the minimum mean square error or some other similar measurement. A curve with higher stability reflects a better set of respiratory rate data for a particular engine. The arbitrator 1630 of
In addition, a slope of the curves 1740, 1760 can be used to assess the quality of the respiratory rate values. A more positive or more negative slope can reflect a trend among respiratory rate values within a processing window. Because a processing window is a relatively short amount of time in certain embodiments, a patient's respiration rate is likely not changing significantly. Thus, a trend can reflect lower quality respiratory rate data. Conversely, a flatter curve can reflect possibly more accurate respiratory rate data. The curve 1740 has a higher slope than the curve 1760, reflecting possibly lower quality respiratory rate data.
At block 1802, for each respiration processor or engine, one or more respiratory rate and confidence values are computed in a processing window. Thus, for example, time domain respiratory rate and confidence values can be calculated, long frequency domain values can be calculated, and short frequency domain values can be calculated. Blocks 1804 through 1820 of the process 1800 are described from the perspective of a single engine. At block 1804, a curve is fit to the respiratory rate values, using any of the techniques described above with respect to
A single confidence value is computed for the processing window at block 1808. This confidence value can be the average of the confidence values of each respiratory rate value calculated in the time domain (with a possible weighting applied with the occurrence value). The confidence value can also be an average for the short frequency domain engine. The confidence value from the long frequency domain engine can be the single confidence value computed (or rather, accessed) at block 1808.
Similarly, a single respiratory rate value is computed for each engine at block 1810. The time domain respiratory rate value can be computed using a simple or weighted average (see
The computed respiratory rate values from each engine are scored at block 1812. This scoring can be based on the stability and/or trend values computed above, among other factors. Other factors might include, for example, how close the respiratory rate value for each engine is. Two engines with close respiratory rate values might be given bonus points in the scoring algorithm, while an outlier is not given bonus points (or is docked points). The score can also be based on the confidence values.
An overall respiratory rate value is selected from the scored respiratory rates at block 1814. The overall respiratory rate value can be selected based at least partly on the scores calculated above with respect to block 1812. Confidence values can be used as a tiebreaker between the respiratory rate values of different engines in certain embodiments. In one embodiment, respiratory rate values from different engines can be combined or averaged to produce the overall respiratory rate value. The combination of the respiratory rate values can be done as a weighted average, for example, using confidence values (or derivatives thereof) as weights.
An overall confidence value is calculated at block 1816. The overall confidence value can be the confidence value of the respiratory rate value that was selected from a particular engine as the overall respiratory rate. If the respiratory rate values from different engines were combined at block 1814, the confidence values may likewise be combined.
As described above, the arbitrator 1630 can average respiratory rate values and confidence values over time, such as a plurality of processing windows. If the overall confidence value is low and the respiratory rate value is therefore considered unreliable, in one embodiment the arbitrator 1630 lengthens this averaging time. The lengthened averaging time can reduce the impact of invalid or low quality respiratory rate values on the overall respiratory rate value output to a display of a patient monitor. Conversely, higher confidence values can cause the arbitrator 1630 to decrease the averaging time.
The modules described herein of certain embodiments may be implemented as software modules, hardware modules, or a combination thereof. In general, the word “module,” as used herein, can refer to logic embodied in hardware or firmware or to a collection of software instructions executable on a processor. Additionally, the modules or components thereof may be implemented in analog circuitry in some embodiments.
Conditional language used herein, such as, among others, “can,” “could,” “might,” “may,” “e.g.,” and the like, unless specifically stated otherwise, or otherwise understood within the context as used, is generally intended to convey that certain embodiments include, while other embodiments do not include, certain features, elements and/or states. Thus, such conditional language is not generally intended to imply that features, elements and/or states are in any way required for one or more embodiments or that one or more embodiments necessarily include logic for deciding, with or without author input or prompting, whether these features, elements and/or states are included or are to be performed in any particular embodiment.
Depending on the embodiment, certain acts, events, or functions of any of the methods described herein can be performed in a different sequence, can be added, merged, or left out all together (e.g., not all described acts or events are necessary for the practice of the method). Moreover, in certain embodiments, acts or events can be performed concurrently, e.g., through multi-threaded processing, interrupt processing, or multiple processors or processor cores, rather than sequentially.
The various illustrative logical blocks, modules, circuits, and algorithm steps described in connection with the embodiments disclosed herein can be implemented as electronic hardware, computer software, or combinations of both. To clearly illustrate this interchangeability of hardware and software, various illustrative components, blocks, modules, circuits, and steps have been described above generally in terms of their functionality. Whether such functionality is implemented as hardware or software depends upon the particular application and design constraints imposed on the overall system. The described functionality can be implemented in varying ways for each particular application, but such implementation decisions should not be interpreted as causing a departure from the scope of the disclosure.
The various illustrative logical blocks, modules, and circuits described in connection with the embodiments disclosed herein can be implemented or performed with a general purpose processor, a digital signal processor (DSP), an application specific integrated circuit (ASIC), a field programmable gate array (FPGA) or other programmable logic device, discrete gate or transistor logic, discrete hardware components, or any combination thereof designed to perform the functions described herein. A general purpose processor can be a microprocessor, but in the alternative, the processor can be any conventional processor, controller, microcontroller, or state machine. A processor can also be implemented as a combination of computing devices, e.g., a combination of a DSP and a microprocessor, a plurality of microprocessors, one or more microprocessors in conjunction with a DSP core, or any other such configuration.
The blocks of the methods and algorithms described in connection with the embodiments disclosed herein can be embodied directly in hardware, in a software module executed by a processor, or in a combination of the two. A software module can reside in RAM memory, flash memory, ROM memory, EPROM memory, EEPROM memory, registers, a hard disk, a removable disk, a CD-ROM, or any other form of computer-readable storage medium known in the art. An exemplary storage medium is coupled to a processor such that the processor can read information from, and write information to, the storage medium. In the alternative, the storage medium can be integral to the processor. The processor and the storage medium can reside in an ASIC. The ASIC can reside in a user terminal. In the alternative, the processor and the storage medium can reside as discrete components in a user terminal.
While the above detailed description has shown, described, and pointed out novel features as applied to various embodiments, it will be understood that various omissions, substitutions, and changes in the form and details of the devices or algorithms illustrated can be made without departing from the spirit of the disclosure. As will be recognized, certain embodiments of the inventions described herein can be embodied within a form that does not provide all of the features and benefits set forth herein, as some features can be used or practiced separately from others. The scope of certain inventions disclosed herein is indicated by the appended claims rather than by the foregoing description. All changes which come within the meaning and range of equivalency of the claims are to be embraced within their scope.
This application is a continuation of U.S. patent application Ser. No. 15/669,201, filed Aug. 4, 2017, entitled “RESPIRATION PROCESSOR,” which is a continuation of U.S. patent application Ser. No. 12/905,384, filed Oct. 15, 2010, entitled “RESPIRATION PROCESSOR,” which claims priority from U.S. Provisional Patent Application No. 61/252,594 filed Oct. 16, 2009, entitled “Respiration Processor,” and from U.S. Provisional Patent Application No. 61/326,200, filed Apr. 20, 2010, entitled “Respiration Processor,” the disclosures of which are hereby incorporated by reference in their entirety.
| Number | Name | Date | Kind |
|---|---|---|---|
| 3682161 | Alibert | Aug 1972 | A |
| 4127749 | Atoji et al. | Nov 1978 | A |
| 4326143 | Guth et al. | Apr 1982 | A |
| 4507653 | Bayer | Mar 1985 | A |
| 4537200 | Widrow | Aug 1985 | A |
| 4685140 | Mount, II | Aug 1987 | A |
| 4714341 | Hamaguri | Dec 1987 | A |
| 4848901 | Hood, Jr. | Jul 1989 | A |
| 4884809 | Rowan | Dec 1989 | A |
| 4958638 | Sharpe et al. | Sep 1990 | A |
| 4960128 | Gordon et al. | Oct 1990 | A |
| 4964408 | Hink et al. | Oct 1990 | A |
| 5033032 | Houghtaling | Jul 1991 | A |
| 5041187 | Hink et al. | Aug 1991 | A |
| 5069213 | Polczynski | Dec 1991 | A |
| 5143078 | Mather et al. | Sep 1992 | A |
| 5163438 | Gordon et al. | Nov 1992 | A |
| 5273036 | Kronberg et al. | Dec 1993 | A |
| 5309922 | Schechter et al. | May 1994 | A |
| 5319355 | Russek | Jun 1994 | A |
| 5337744 | Branigan | Aug 1994 | A |
| 5341805 | Stavridi et al. | Aug 1994 | A |
| 5353798 | Sieben | Oct 1994 | A |
| D353195 | Savage et al. | Dec 1994 | S |
| D353196 | Savage et al. | Dec 1994 | S |
| 5377302 | Tsiang | Dec 1994 | A |
| 5377676 | Vari et al. | Jan 1995 | A |
| D359546 | Savage et al. | Jun 1995 | S |
| 5431170 | Mathews | Jul 1995 | A |
| 5436499 | Namavar et al. | Jul 1995 | A |
| D361840 | Savage et al. | Aug 1995 | S |
| D362063 | Savage et al. | Sep 1995 | S |
| 5448996 | Bellin et al. | Sep 1995 | A |
| 5452717 | Branigan et al. | Sep 1995 | A |
| D363120 | Savage et al. | Oct 1995 | S |
| 5456252 | Vari et al. | Oct 1995 | A |
| 5479934 | Imran | Jan 1996 | A |
| 5482036 | Diab et al. | Jan 1996 | A |
| 5490505 | Diab et al. | Feb 1996 | A |
| 5494043 | O'Sullivan et al. | Feb 1996 | A |
| 5533511 | Kaspari et al. | Jul 1996 | A |
| 5534851 | Russek | Jul 1996 | A |
| 5561275 | Savage et al. | Oct 1996 | A |
| 5562002 | Lalin | Oct 1996 | A |
| 5590649 | Caro et al. | Jan 1997 | A |
| 5602924 | Durand et al. | Feb 1997 | A |
| 5632272 | Diab et al. | May 1997 | A |
| 5638403 | Birchler et al. | Jun 1997 | A |
| 5638816 | Kiani-Azarbayjany et al. | Jun 1997 | A |
| 5638818 | Diab et al. | Jun 1997 | A |
| 5645440 | Tobler et al. | Jul 1997 | A |
| 5671191 | Gerdt | Sep 1997 | A |
| 5671914 | Kalkhoran et al. | Sep 1997 | A |
| 5685299 | Diab et al. | Nov 1997 | A |
| 5724983 | Selker et al. | Mar 1998 | A |
| 5726440 | Kalkhoran et al. | Mar 1998 | A |
| D393830 | Tobler et al. | Apr 1998 | S |
| 5743262 | Lepper, Jr. et al. | Apr 1998 | A |
| 5747806 | Khalil et al. | May 1998 | A |
| 5750994 | Schlager | May 1998 | A |
| 5758644 | Diab et al. | Jun 1998 | A |
| 5760910 | Lepper, Jr. et al. | Jun 1998 | A |
| 5769785 | Diab et al. | Jun 1998 | A |
| 5782757 | Diab et al. | Jul 1998 | A |
| 5785659 | Caro et al. | Jul 1998 | A |
| 5791347 | Flaherty et al. | Aug 1998 | A |
| 5810734 | Caro et al. | Sep 1998 | A |
| 5819007 | Elghazzawi | Oct 1998 | A |
| 5823950 | Diab et al. | Oct 1998 | A |
| 5830131 | Caro et al. | Nov 1998 | A |
| 5833618 | Caro et al. | Nov 1998 | A |
| 5860919 | Kiani-Azarbayjany et al. | Jan 1999 | A |
| 5865168 | Isaza | Feb 1999 | A |
| 5865736 | Baker, Jr. et al. | Feb 1999 | A |
| 5890929 | Mills et al. | Apr 1999 | A |
| 5904654 | Wohltmann et al. | May 1999 | A |
| 5919134 | Diab | Jul 1999 | A |
| 5928156 | Krumbiegel | Jul 1999 | A |
| 5934925 | Tobler et al. | Aug 1999 | A |
| 5940182 | Lepper, Jr. et al. | Aug 1999 | A |
| 5987343 | Kinast | Nov 1999 | A |
| 5995855 | Kiani et al. | Nov 1999 | A |
| 5997343 | Mills et al. | Dec 1999 | A |
| 6002952 | Diab et al. | Dec 1999 | A |
| 6010937 | Karam et al. | Jan 2000 | A |
| 6011986 | Diab et al. | Jan 2000 | A |
| 6027452 | Flaherty et al. | Feb 2000 | A |
| 6029665 | Berthon-Jones | Feb 2000 | A |
| 6036642 | Diab et al. | Mar 2000 | A |
| 6040578 | Malin et al. | Mar 2000 | A |
| 6045509 | Caro et al. | Apr 2000 | A |
| 6064910 | Andersson et al. | May 2000 | A |
| 6066204 | Haven | May 2000 | A |
| 6067462 | Diab et al. | May 2000 | A |
| 6081735 | Diab et al. | Jun 2000 | A |
| 6083172 | Baker et al. | Jul 2000 | A |
| 6088607 | Diab et al. | Jul 2000 | A |
| 6091973 | Colla et al. | Jul 2000 | A |
| 6110522 | Lepper, Jr. et al. | Aug 2000 | A |
| 6112171 | Sugiyama et al. | Aug 2000 | A |
| 6115673 | Malin et al. | Sep 2000 | A |
| 6124597 | Shehada | Sep 2000 | A |
| 6128521 | Marro et al. | Oct 2000 | A |
| 6129675 | Jay | Oct 2000 | A |
| 6138675 | Berthon-Jones | Oct 2000 | A |
| 6139505 | Murphy | Oct 2000 | A |
| 6144868 | Parker | Nov 2000 | A |
| 6151516 | Kiani-Azarbayjany et al. | Nov 2000 | A |
| 6152754 | Gerhardt et al. | Nov 2000 | A |
| 6157850 | Diab et al. | Dec 2000 | A |
| 6165005 | Mills et al. | Dec 2000 | A |
| 6168568 | Gavriely | Jan 2001 | B1 |
| 6178343 | Bindszus et al. | Jan 2001 | B1 |
| 6184521 | Coffin, IV et al. | Feb 2001 | B1 |
| 6206830 | Diab et al. | Mar 2001 | B1 |
| 6229856 | Diab et al. | May 2001 | B1 |
| 6232609 | Snyder et al. | May 2001 | B1 |
| 6236872 | Diab et al. | May 2001 | B1 |
| 6241683 | Macklem et al. | Jun 2001 | B1 |
| 6248083 | Smith et al. | Jun 2001 | B1 |
| 6253097 | Aronow et al. | Jun 2001 | B1 |
| 6254551 | Varis | Jul 2001 | B1 |
| 6255708 | Sudharsanan et al. | Jul 2001 | B1 |
| 6256523 | Diab et al. | Jul 2001 | B1 |
| 6261238 | Gavriely | Jul 2001 | B1 |
| 6263222 | Diab et al. | Jul 2001 | B1 |
| 6278522 | Lepper, Jr. et al. | Aug 2001 | B1 |
| 6280213 | Tobler et al. | Aug 2001 | B1 |
| 6280381 | Malin et al. | Aug 2001 | B1 |
| 6285896 | Tobler et al. | Sep 2001 | B1 |
| 6301493 | Marro et al. | Oct 2001 | B1 |
| 6308089 | von der Ruhr et al. | Oct 2001 | B1 |
| 6317627 | Ennen et al. | Nov 2001 | B1 |
| 6321100 | Parker | Nov 2001 | B1 |
| 6325761 | Jay | Dec 2001 | B1 |
| 6331162 | Mitchell | Dec 2001 | B1 |
| 6334065 | Al-Ali et al. | Dec 2001 | B1 |
| 6343224 | Parker | Jan 2002 | B1 |
| 6349228 | Kiani et al. | Feb 2002 | B1 |
| 6360114 | Diab et al. | Mar 2002 | B1 |
| 6368283 | Xu et al. | Apr 2002 | B1 |
| 6371921 | Caro et al. | Apr 2002 | B1 |
| 6377829 | Al-Ali | Apr 2002 | B1 |
| 6383143 | Rost | May 2002 | B1 |
| 6388240 | Schulz et al. | May 2002 | B2 |
| 6397091 | Diab et al. | May 2002 | B2 |
| 6411373 | Garside et al. | Jun 2002 | B1 |
| 6415167 | Blank et al. | Jul 2002 | B1 |
| 6430437 | Marro | Aug 2002 | B1 |
| 6430525 | Weber et al. | Aug 2002 | B1 |
| 6443907 | Mansy et al. | Sep 2002 | B1 |
| 6463311 | Diab | Oct 2002 | B1 |
| 6470199 | Kopotic et al. | Oct 2002 | B1 |
| 6486588 | Doron et al. | Nov 2002 | B2 |
| 6487429 | Hockersmith et al. | Nov 2002 | B2 |
| 6491647 | Bridger et al. | Dec 2002 | B1 |
| 6501975 | Diab et al. | Dec 2002 | B2 |
| 6505059 | Kollias et al. | Jan 2003 | B1 |
| 6515273 | Al-Ali | Feb 2003 | B2 |
| 6517497 | Rymut et al. | Feb 2003 | B2 |
| 6519487 | Parker | Feb 2003 | B1 |
| 6525386 | Mills et al. | Feb 2003 | B1 |
| 6526300 | Kiani et al. | Feb 2003 | B1 |
| 6534012 | Hazen et al. | Mar 2003 | B1 |
| 6541756 | Schulz et al. | Apr 2003 | B2 |
| 6542764 | Al-Ali et al. | Apr 2003 | B1 |
| 6580086 | Schulz et al. | Jun 2003 | B1 |
| 6584336 | Ali et al. | Jun 2003 | B1 |
| 6587196 | Stippick et al. | Jul 2003 | B1 |
| 6587199 | Luu | Jul 2003 | B1 |
| 6595316 | Cybulski et al. | Jul 2003 | B2 |
| 6597932 | Tian et al. | Jul 2003 | B2 |
| 6597933 | Kiani et al. | Jul 2003 | B2 |
| 6606511 | Ali et al. | Aug 2003 | B1 |
| 6632181 | Flaherty et al. | Oct 2003 | B2 |
| 6635559 | Greenwald et al. | Oct 2003 | B2 |
| 6639668 | Trepagnier | Oct 2003 | B1 |
| 6640116 | Diab | Oct 2003 | B2 |
| 6640117 | Makarewicz et al. | Oct 2003 | B2 |
| 6643530 | Diab et al. | Nov 2003 | B2 |
| 6647280 | Bahr et al. | Nov 2003 | B2 |
| 6650917 | Diab et al. | Nov 2003 | B2 |
| 6654624 | Diab et al. | Nov 2003 | B2 |
| 6658276 | Kiani et al. | Dec 2003 | B2 |
| 6659960 | Derksen et al. | Dec 2003 | B2 |
| 6661161 | Lanzo et al. | Dec 2003 | B1 |
| 6671531 | Al-Ali et al. | Dec 2003 | B2 |
| 6678543 | Diab et al. | Jan 2004 | B2 |
| 6684090 | Ali et al. | Jan 2004 | B2 |
| 6684091 | Parker | Jan 2004 | B2 |
| 6697656 | Al-Ali | Feb 2004 | B1 |
| 6697657 | Shehada et al. | Feb 2004 | B1 |
| 6697658 | Al-Ali | Feb 2004 | B2 |
| RE38476 | Diab et al. | Mar 2004 | E |
| 6699194 | Diab et al. | Mar 2004 | B1 |
| 6709402 | Dekker | Mar 2004 | B2 |
| 6714804 | Al-Ali et al. | Mar 2004 | B2 |
| RE38492 | Diab et al. | Apr 2004 | E |
| 6721582 | Trepagnier et al. | Apr 2004 | B2 |
| 6721585 | Parker | Apr 2004 | B1 |
| 6725074 | Kastle | Apr 2004 | B1 |
| 6725075 | Al-Ali | Apr 2004 | B2 |
| 6728560 | Kollias et al. | Apr 2004 | B2 |
| 6735459 | Parker | May 2004 | B2 |
| 6738652 | Mattu et al. | May 2004 | B2 |
| 6745060 | Diab et al. | Jun 2004 | B2 |
| 6754516 | Mannheimer | Jun 2004 | B2 |
| 6760607 | Al-Ali | Jul 2004 | B2 |
| 6766038 | Sakuma et al. | Jul 2004 | B1 |
| 6770028 | Ali et al. | Aug 2004 | B1 |
| 6771994 | Kiani et al. | Aug 2004 | B2 |
| 6788965 | Ruchti et al. | Sep 2004 | B2 |
| 6792300 | Diab et al. | Sep 2004 | B1 |
| 6813511 | Diab et al. | Nov 2004 | B2 |
| 6816241 | Grubisic | Nov 2004 | B2 |
| 6816741 | Diab | Nov 2004 | B2 |
| 6822564 | Al-Ali | Nov 2004 | B2 |
| 6826419 | Diab et al. | Nov 2004 | B2 |
| 6830711 | Mills et al. | Dec 2004 | B2 |
| 6839581 | El-Solh et al. | Jan 2005 | B1 |
| 6850787 | Weber et al. | Feb 2005 | B2 |
| 6850788 | Al-Ali | Feb 2005 | B2 |
| 6852083 | Caro et al. | Feb 2005 | B2 |
| 6861639 | Al-Ali | Mar 2005 | B2 |
| 6869402 | Arnold | Mar 2005 | B2 |
| 6876931 | Lorenz et al. | Apr 2005 | B2 |
| 6898452 | Al-Ali et al. | May 2005 | B2 |
| 6920345 | Al-Ali et al. | Jul 2005 | B2 |
| 6931268 | Kiani-Azarbayjany et al. | Aug 2005 | B1 |
| 6934570 | Kiani et al. | Aug 2005 | B2 |
| 6939305 | Flaherty et al. | Sep 2005 | B2 |
| 6943348 | Coffin, IV | Sep 2005 | B1 |
| 6950687 | Al-Ali | Sep 2005 | B2 |
| 6956649 | Acosta et al. | Oct 2005 | B2 |
| 6961598 | Diab | Nov 2005 | B2 |
| 6970792 | Diab | Nov 2005 | B1 |
| 6979812 | Al-Ali | Dec 2005 | B2 |
| 6985764 | Mason et al. | Jan 2006 | B2 |
| 6990364 | Ruchti et al. | Jan 2006 | B2 |
| 6993371 | Kiani et al. | Jan 2006 | B2 |
| 6996427 | Ali et al. | Feb 2006 | B2 |
| 6998247 | Monfre et al. | Feb 2006 | B2 |
| 6999904 | Weber et al. | Feb 2006 | B2 |
| 7003338 | Weber et al. | Feb 2006 | B2 |
| 7003339 | Diab et al. | Feb 2006 | B2 |
| 7015451 | Dalke et al. | Mar 2006 | B2 |
| 7024233 | Ali et al. | Apr 2006 | B2 |
| 7027849 | Al-Ali | Apr 2006 | B2 |
| 7030749 | Al-Ali | Apr 2006 | B2 |
| 7039449 | Al-Ali | May 2006 | B2 |
| 7041060 | Flaherty et al. | May 2006 | B2 |
| 7044918 | Diab | May 2006 | B2 |
| 7067893 | Mills et al. | Jun 2006 | B2 |
| D526719 | Richie, Jr. et al. | Aug 2006 | S |
| 7096052 | Mason et al. | Aug 2006 | B2 |
| 7096054 | Abdul-Hafiz et al. | Aug 2006 | B2 |
| 7096060 | Arand et al. | Aug 2006 | B2 |
| D529616 | Deros et al. | Oct 2006 | S |
| 7132641 | Schulz et al. | Nov 2006 | B2 |
| 7133710 | Acosta et al. | Nov 2006 | B2 |
| 7142901 | Kiani et al. | Nov 2006 | B2 |
| 7149561 | Diab | Dec 2006 | B2 |
| 7186966 | Al-Ali | Mar 2007 | B2 |
| 7190261 | Al-Ali | Mar 2007 | B2 |
| 7194306 | Turcott | Mar 2007 | B1 |
| 7215984 | Diab | May 2007 | B2 |
| 7215986 | Diab | May 2007 | B2 |
| 7221971 | Diab | May 2007 | B2 |
| 7225006 | Al-Ali et al. | May 2007 | B2 |
| 7225007 | Al-Ali | May 2007 | B2 |
| RE39672 | Shehada et al. | Jun 2007 | E |
| 7239905 | Kiani-Azarbayjany et al. | Jul 2007 | B2 |
| 7245953 | Parker | Jul 2007 | B1 |
| 7254429 | Schurman et al. | Aug 2007 | B2 |
| 7254431 | Al-Ali | Aug 2007 | B2 |
| 7254433 | Diab et al. | Aug 2007 | B2 |
| 7254434 | Schulz et al. | Aug 2007 | B2 |
| 7267652 | Coyle et al. | Sep 2007 | B2 |
| 7272425 | Al-Ali | Sep 2007 | B2 |
| 7274955 | Kiani et al. | Sep 2007 | B2 |
| D554263 | Al-Ali | Oct 2007 | S |
| 7280858 | Al-Ali et al. | Oct 2007 | B2 |
| 7289835 | Mansfield et al. | Oct 2007 | B2 |
| 7292883 | De Felice et al. | Nov 2007 | B2 |
| 7295866 | Al-Ali | Nov 2007 | B2 |
| 7328053 | Diab et al. | Feb 2008 | B1 |
| 7332784 | Mills et al. | Feb 2008 | B2 |
| 7340287 | Mason et al. | Mar 2008 | B2 |
| 7341559 | Schulz et al. | Mar 2008 | B2 |
| 7343186 | Lamego et al. | Mar 2008 | B2 |
| D566282 | Al-Ali et al. | Apr 2008 | S |
| 7355512 | Al-Ali | Apr 2008 | B1 |
| 7356365 | Schurman | Apr 2008 | B2 |
| 7361146 | Bharmi et al. | Apr 2008 | B1 |
| 7371981 | Abdul-Hafiz | May 2008 | B2 |
| 7373193 | Al-Ali et al. | May 2008 | B2 |
| 7373194 | Weber et al. | May 2008 | B2 |
| 7376453 | Diab et al. | May 2008 | B1 |
| 7377794 | Al Ali et al. | May 2008 | B2 |
| 7377899 | Weber et al. | May 2008 | B2 |
| 7383070 | Diab et al. | Jun 2008 | B2 |
| 7395158 | Monfre et al. | Jul 2008 | B2 |
| 7398115 | Lynn | Jul 2008 | B2 |
| 7415297 | Al-Ali et al. | Aug 2008 | B2 |
| 7428432 | Ali et al. | Sep 2008 | B2 |
| 7438683 | Al-Ali et al. | Oct 2008 | B2 |
| 7440787 | Diab | Oct 2008 | B2 |
| 7454240 | Diab et al. | Nov 2008 | B2 |
| 7467002 | Weber et al. | Dec 2008 | B2 |
| 7469157 | Diab et al. | Dec 2008 | B2 |
| 7471969 | Diab et al. | Dec 2008 | B2 |
| 7471971 | Diab et al. | Dec 2008 | B2 |
| 7483729 | Al-Ali et al. | Jan 2009 | B2 |
| 7483730 | Diab et al. | Jan 2009 | B2 |
| 7489958 | Diab et al. | Feb 2009 | B2 |
| 7496391 | Diab et al. | Feb 2009 | B2 |
| 7496393 | Diab et al. | Feb 2009 | B2 |
| D587657 | Al-Ali et al. | Mar 2009 | S |
| 7499741 | Diab et al. | Mar 2009 | B2 |
| 7499835 | Weber et al. | Mar 2009 | B2 |
| 7500950 | Al-Ali et al. | Mar 2009 | B2 |
| 7509154 | Diab et al. | Mar 2009 | B2 |
| 7509494 | Al-Ali | Mar 2009 | B2 |
| 7510849 | Schurman et al. | Mar 2009 | B2 |
| 7514725 | Wojtczuk et al. | Apr 2009 | B2 |
| 7519406 | Blank et al. | Apr 2009 | B2 |
| 7526328 | Diab et al. | Apr 2009 | B2 |
| D592507 | Wachman et al. | May 2009 | S |
| 7530942 | Diab | May 2009 | B1 |
| 7530949 | Al Ali et al. | May 2009 | B2 |
| 7530955 | Diab et al. | May 2009 | B2 |
| 7539533 | Tran | May 2009 | B2 |
| 7563110 | Al-Ali et al. | Jul 2009 | B2 |
| 7593230 | Abul-Haj et al. | Sep 2009 | B2 |
| 7596398 | Al-Ali et al. | Sep 2009 | B2 |
| 7606608 | Blank et al. | Oct 2009 | B2 |
| 7618375 | Flaherty | Nov 2009 | B2 |
| 7620674 | Ruchti et al. | Nov 2009 | B2 |
| D606659 | Kiani et al. | Dec 2009 | S |
| 7629039 | Eckerbom et al. | Dec 2009 | B2 |
| 7640140 | Ruchti et al. | Dec 2009 | B2 |
| 7647083 | Al-Ali et al. | Jan 2010 | B2 |
| D609193 | Al-Ali et al. | Feb 2010 | S |
| D614305 | Al-Ali et al. | Apr 2010 | S |
| 7690378 | Turcott | Apr 2010 | B1 |
| 7697966 | Monfre et al. | Apr 2010 | B2 |
| 7698105 | Ruchti et al. | Apr 2010 | B2 |
| RE41317 | Parker | May 2010 | E |
| RE41333 | Blank et al. | May 2010 | E |
| 7729733 | Al-Ali et al. | Jun 2010 | B2 |
| 7734320 | Al-Ali | Jun 2010 | B2 |
| 7761127 | Al-Ali et al. | Jul 2010 | B2 |
| 7761128 | Al-Ali et al. | Jul 2010 | B2 |
| 7764982 | Dalke et al. | Jul 2010 | B2 |
| D621516 | Kiani et al. | Aug 2010 | S |
| 7791155 | Diab | Sep 2010 | B2 |
| 7801581 | Diab | Sep 2010 | B2 |
| 7822452 | Schurman et al. | Oct 2010 | B2 |
| RE41912 | Parker | Nov 2010 | E |
| 7844313 | Kiani et al. | Nov 2010 | B2 |
| 7844314 | Al-Ali | Nov 2010 | B2 |
| 7844315 | Al-Ali | Nov 2010 | B2 |
| 7865222 | Weber et al. | Jan 2011 | B2 |
| 7873497 | Weber et al. | Jan 2011 | B2 |
| 7880606 | Al-Ali | Feb 2011 | B2 |
| 7880626 | Al-Ali et al. | Feb 2011 | B2 |
| 7891355 | Al-Ali et al. | Feb 2011 | B2 |
| 7894868 | Al-Ali et al. | Feb 2011 | B2 |
| 7899507 | Al-Ali et al. | Mar 2011 | B2 |
| 7899518 | Trepagnier et al. | Mar 2011 | B2 |
| 7904132 | Weber et al. | Mar 2011 | B2 |
| 7909772 | Popov et al. | Mar 2011 | B2 |
| 7910875 | Al-Ali | Mar 2011 | B2 |
| 7919713 | Al-Ali et al. | Apr 2011 | B2 |
| 7937128 | Al-Ali | May 2011 | B2 |
| 7937129 | Mason et al. | May 2011 | B2 |
| 7937130 | Diab et al. | May 2011 | B2 |
| 7941199 | Kiani | May 2011 | B2 |
| 7951086 | Flaherty et al. | May 2011 | B2 |
| 7957780 | Lamego et al. | Jun 2011 | B2 |
| 7962188 | Kiani et al. | Jun 2011 | B2 |
| 7962190 | Diab et al. | Jun 2011 | B1 |
| 7976472 | Kiani | Jul 2011 | B2 |
| 7988637 | Diab | Aug 2011 | B2 |
| 7990382 | Kiani | Aug 2011 | B2 |
| 7991446 | Al-Ali et al. | Aug 2011 | B2 |
| 8000761 | Al-Ali | Aug 2011 | B2 |
| 8008088 | Bellott et al. | Aug 2011 | B2 |
| RE42753 | Kiani-Azarbayjany et al. | Sep 2011 | E |
| 8019400 | Diab et al. | Sep 2011 | B2 |
| 8028701 | Al-Ali et al. | Oct 2011 | B2 |
| 8029765 | Bellott et al. | Oct 2011 | B2 |
| 8036727 | Schurman et al. | Oct 2011 | B2 |
| 8036728 | Diab et al. | Oct 2011 | B2 |
| 8046040 | Ali et al. | Oct 2011 | B2 |
| 8046041 | Diab et al. | Oct 2011 | B2 |
| 8046042 | Diab et al. | Oct 2011 | B2 |
| 8048040 | Kiani | Nov 2011 | B2 |
| 8050728 | Al-Ali et al. | Nov 2011 | B2 |
| RE43169 | Parker | Feb 2012 | E |
| 8118620 | Al-Ali et al. | Feb 2012 | B2 |
| 8126528 | Diab et al. | Feb 2012 | B2 |
| 8128572 | Diab et al. | Mar 2012 | B2 |
| 8130105 | Al-Ali et al. | Mar 2012 | B2 |
| 8145287 | Diab et al. | Mar 2012 | B2 |
| 8150487 | Diab et al. | Apr 2012 | B2 |
| 8175672 | Parker | May 2012 | B2 |
| 8180420 | Diab et al. | May 2012 | B2 |
| 8182443 | Kiani | May 2012 | B1 |
| 8185180 | Diab et al. | May 2012 | B2 |
| 8190223 | Al-Ali et al. | May 2012 | B2 |
| 8190227 | Diab et al. | May 2012 | B2 |
| 8203438 | Kiani et al. | Jun 2012 | B2 |
| 8203704 | Merritt et al. | Jun 2012 | B2 |
| 8204566 | Schurman et al. | Jun 2012 | B2 |
| 8219172 | Schurman et al. | Jul 2012 | B2 |
| 8224411 | Al-Ali et al. | Jul 2012 | B2 |
| 8228181 | Al-Ali | Jul 2012 | B2 |
| 8229532 | Davis | Jul 2012 | B2 |
| 8229533 | Diab et al. | Jul 2012 | B2 |
| 8233955 | Al-Ali et al. | Jul 2012 | B2 |
| 8244325 | Al-Ali et al. | Aug 2012 | B2 |
| 8255026 | Al-Ali | Aug 2012 | B1 |
| 8255027 | Al-Ali et al. | Aug 2012 | B2 |
| 8255028 | Al-Ali et al. | Aug 2012 | B2 |
| 8260577 | Weber et al. | Sep 2012 | B2 |
| 8265723 | McHale et al. | Sep 2012 | B1 |
| 8274360 | Sampath et al. | Sep 2012 | B2 |
| 8280473 | Al-Ali | Oct 2012 | B2 |
| 8301217 | Al-Ali et al. | Oct 2012 | B2 |
| 8306596 | Schurman et al. | Nov 2012 | B2 |
| 8310336 | Muhsin et al. | Nov 2012 | B2 |
| 8315683 | Al-Ali et al. | Nov 2012 | B2 |
| RE43860 | Parker | Dec 2012 | E |
| 8337403 | Al-Ali et al. | Dec 2012 | B2 |
| 8346330 | Lamego | Jan 2013 | B2 |
| 8353842 | Al-Ali et al. | Jan 2013 | B2 |
| 8355766 | MacNeish, III et al. | Jan 2013 | B2 |
| 8359080 | Diab et al. | Jan 2013 | B2 |
| 8364223 | Al-Ali et al. | Jan 2013 | B2 |
| 8364226 | Diab et al. | Jan 2013 | B2 |
| 8374665 | Lamego | Feb 2013 | B2 |
| 8385995 | Al-ali et al. | Feb 2013 | B2 |
| 8385996 | Smith et al. | Feb 2013 | B2 |
| 8388353 | Kiani et al. | Mar 2013 | B2 |
| 8399822 | Al-Ali | Mar 2013 | B2 |
| 8401602 | Kiani | Mar 2013 | B2 |
| 8405608 | Al-Ali et al. | Mar 2013 | B2 |
| 8414499 | Al-Ali et al. | Apr 2013 | B2 |
| 8418524 | Al-Ali | Apr 2013 | B2 |
| 8423106 | Lamego et al. | Apr 2013 | B2 |
| 8428967 | Olsen et al. | Apr 2013 | B2 |
| 8430817 | Al-Ali et al. | Apr 2013 | B1 |
| 8437825 | Dalvi et al. | May 2013 | B2 |
| 8455290 | Siskavich | Jun 2013 | B2 |
| 8457703 | Al-Ali | Jun 2013 | B2 |
| 8457707 | Kiani | Jun 2013 | B2 |
| 8463349 | Diab et al. | Jun 2013 | B2 |
| 8466286 | Bellot et al. | Jun 2013 | B2 |
| 8471713 | Poeze et al. | Jun 2013 | B2 |
| 8473020 | Kiani et al. | Jun 2013 | B2 |
| 8478538 | McGonigle et al. | Jul 2013 | B2 |
| 8483787 | Al-Ali et al. | Jul 2013 | B2 |
| 8489364 | Weber et al. | Jul 2013 | B2 |
| 8498684 | Weber et al. | Jul 2013 | B2 |
| 8504128 | Blank et al. | Aug 2013 | B2 |
| 8509867 | Workman et al. | Aug 2013 | B2 |
| 8515509 | Bruinsma et al. | Aug 2013 | B2 |
| 8523781 | Al-Ali | Sep 2013 | B2 |
| 8529301 | Al-Ali et al. | Sep 2013 | B2 |
| 8532727 | Ali et al. | Sep 2013 | B2 |
| 8532728 | Diab et al. | Sep 2013 | B2 |
| D692145 | Al-Ali et al. | Oct 2013 | S |
| 8547209 | Kiani et al. | Oct 2013 | B2 |
| 8548548 | Al-Ali | Oct 2013 | B2 |
| 8548549 | Schurman et al. | Oct 2013 | B2 |
| 8548550 | Al-Ali et al. | Oct 2013 | B2 |
| 8560032 | Al-Ali et al. | Oct 2013 | B2 |
| 8560034 | Diab et al. | Oct 2013 | B1 |
| 8570167 | Al-Ali | Oct 2013 | B2 |
| 8570503 | Vo et al. | Oct 2013 | B2 |
| 8571617 | Reichgott et al. | Oct 2013 | B2 |
| 8571618 | Lamego et al. | Oct 2013 | B1 |
| 8571619 | Al-Ali et al. | Oct 2013 | B2 |
| 8584345 | Al-Ali et al. | Oct 2013 | B2 |
| 8577431 | Lamego et al. | Nov 2013 | B2 |
| 8581732 | Al-Ali et al. | Nov 2013 | B2 |
| 8588880 | Abdul-Hafiz et al. | Nov 2013 | B2 |
| 8597274 | Sloan | Dec 2013 | B2 |
| 8600467 | Al-Ali et al. | Dec 2013 | B2 |
| 8606342 | Diab | Dec 2013 | B2 |
| 8622902 | Woehrle | Jan 2014 | B2 |
| 8626255 | Al-Ali et al. | Jan 2014 | B2 |
| 8630691 | Lamego et al. | Jan 2014 | B2 |
| 8634889 | Al-Ali et al. | Jan 2014 | B2 |
| 8641631 | Sierra et al. | Feb 2014 | B2 |
| 8652060 | Al-Ali | Feb 2014 | B2 |
| 8663107 | Kiani | Mar 2014 | B2 |
| 8666468 | Al-Ali | Mar 2014 | B1 |
| 8667967 | Al-Ali et al. | Mar 2014 | B2 |
| 8670811 | O'Reilly | Mar 2014 | B2 |
| 8670814 | Diab et al. | Mar 2014 | B2 |
| 8676286 | Weber et al. | Mar 2014 | B2 |
| 8682407 | Al-Ali | Mar 2014 | B2 |
| RE44823 | Parker | Apr 2014 | E |
| RE44875 | Kiani et al. | Apr 2014 | E |
| 8688183 | Bruinsma et al. | Apr 2014 | B2 |
| 8690799 | Telfort et al. | Apr 2014 | B2 |
| 8700112 | Kiani | Apr 2014 | B2 |
| 8702627 | Telfort et al. | Apr 2014 | B2 |
| 8706179 | Parker | Apr 2014 | B2 |
| 8712494 | MacNeish, III et al. | Apr 2014 | B1 |
| 8715206 | Telfort et al. | May 2014 | B2 |
| 8718735 | Lamego et al. | May 2014 | B2 |
| 8718737 | Diab et al. | May 2014 | B2 |
| 8718738 | Blank et al. | May 2014 | B2 |
| 8720249 | Al-Ali | May 2014 | B2 |
| 8721541 | Al-Ali et al. | May 2014 | B2 |
| 8721542 | Al-Ali et al. | May 2014 | B2 |
| 8723677 | Kiani | May 2014 | B1 |
| 8740792 | Kiani et al. | Jun 2014 | B1 |
| 8754776 | Poeze et al. | Jun 2014 | B2 |
| 8755535 | Telfort et al. | Jun 2014 | B2 |
| 8755856 | Diab et al. | Jun 2014 | B2 |
| 8755872 | Marinow | Jun 2014 | B1 |
| 8761850 | Lamego | Jun 2014 | B2 |
| 8764671 | Kiani | Jul 2014 | B2 |
| 8768423 | Shakespeare et al. | Jul 2014 | B2 |
| 8771204 | Telfort et al. | Jul 2014 | B2 |
| 8777634 | Kiani et al. | Jul 2014 | B2 |
| 8781543 | Diab et al. | Jul 2014 | B2 |
| 8781544 | Al-Ali et al. | Jul 2014 | B2 |
| 8781549 | Al-Ali et al. | Jul 2014 | B2 |
| 8788003 | Schurman et al. | Jul 2014 | B2 |
| 8790268 | Al-Ali | Jul 2014 | B2 |
| 8792949 | Baker | Jul 2014 | B2 |
| 8801613 | Al-Ali et al. | Aug 2014 | B2 |
| 8821397 | Al-Ali et al. | Sep 2014 | B2 |
| 8821415 | Al-Ali et al. | Sep 2014 | B2 |
| 8830449 | Lamego et al. | Sep 2014 | B1 |
| 8831700 | Schurman et al. | Sep 2014 | B2 |
| 8840549 | Al-Ali et al. | Sep 2014 | B2 |
| 8847740 | Kiani et al. | Sep 2014 | B2 |
| 8849365 | Smith et al. | Sep 2014 | B2 |
| 8852094 | Al-Ali et al. | Oct 2014 | B2 |
| 8852994 | Wojtczuk et al. | Oct 2014 | B2 |
| 8868147 | Stippick et al. | Oct 2014 | B2 |
| 8868150 | Al-Ali et al. | Oct 2014 | B2 |
| 8870792 | Al-Ali et al. | Oct 2014 | B2 |
| 8886271 | Kiani et al. | Nov 2014 | B2 |
| 8888539 | Al-Ali et al. | Nov 2014 | B2 |
| 8888708 | Diab et al. | Nov 2014 | B2 |
| 8892180 | Weber et al. | Nov 2014 | B2 |
| 8897847 | Al-Ali | Nov 2014 | B2 |
| 8909310 | Lamego | Dec 2014 | B2 |
| 8911377 | Al-Ali | Dec 2014 | B2 |
| 8912909 | Al-Ali et al. | Dec 2014 | B2 |
| 8920317 | Al-Ali et al. | Dec 2014 | B2 |
| 8921699 | Al-Ali et al. | Dec 2014 | B2 |
| 8922382 | Al-Ali et al. | Dec 2014 | B2 |
| 8929964 | Al-Ali et al. | Jan 2015 | B2 |
| 8942777 | Diab et al. | Jan 2015 | B2 |
| 8948834 | Diab et al. | Feb 2015 | B2 |
| 8948835 | Diab | Feb 2015 | B2 |
| 8965471 | Lamego | Feb 2015 | B2 |
| 8983564 | Al-Ali | Mar 2015 | B2 |
| 8989831 | Al-Ali et al. | Mar 2015 | B2 |
| 8996085 | Kiani et al. | Mar 2015 | B2 |
| 8998809 | Kiani | Apr 2015 | B2 |
| 9028429 | Telfort et al. | May 2015 | B2 |
| 9037207 | Al-Ali et al. | May 2015 | B2 |
| 9060721 | Reichgott et al. | Jun 2015 | B2 |
| 9066666 | Kiani | Jun 2015 | B2 |
| 9066680 | Al-Ali et al. | Jun 2015 | B1 |
| 9072474 | Al-Ali et al. | Jul 2015 | B2 |
| 9078560 | Schurman et al. | Jul 2015 | B2 |
| 9084569 | Weber et al. | Jul 2015 | B2 |
| 9095316 | Welch et al. | Aug 2015 | B2 |
| 9106038 | Telfort et al. | Aug 2015 | B2 |
| 9107625 | Telfort et al. | Aug 2015 | B2 |
| 9107626 | Al-Ali et al. | Aug 2015 | B2 |
| 9113831 | Al-Ali | Aug 2015 | B2 |
| 9113832 | Al-Ali | Aug 2015 | B2 |
| 9119595 | Lamego | Sep 2015 | B2 |
| 9131881 | Diab et al. | Sep 2015 | B2 |
| 9131882 | Al-Ali et al. | Sep 2015 | B2 |
| 9131883 | Al-Ali | Sep 2015 | B2 |
| 9131917 | Telfort et al. | Sep 2015 | B2 |
| 9135398 | Kaib | Sep 2015 | B2 |
| 9138180 | Coverston et al. | Sep 2015 | B1 |
| 9138182 | Al-Ali et al. | Sep 2015 | B2 |
| 9138192 | Weber et al. | Sep 2015 | B2 |
| 9142117 | Muhsin et al. | Sep 2015 | B2 |
| 9153112 | Kiani et al. | Oct 2015 | B1 |
| 9153121 | Kiani et al. | Oct 2015 | B2 |
| 9161696 | Al-Ali et al. | Oct 2015 | B2 |
| 9161713 | Al-Ali et al. | Oct 2015 | B2 |
| 9167995 | Lamego et al. | Oct 2015 | B2 |
| 9176141 | Al-Ali et al. | Nov 2015 | B2 |
| 9186102 | Bruinsma et al. | Nov 2015 | B2 |
| 9192312 | Al-Ali | Nov 2015 | B2 |
| 9192329 | Al-Ali | Nov 2015 | B2 |
| 9192351 | Telfort et al. | Nov 2015 | B1 |
| 9195385 | Al-Ali et al. | Nov 2015 | B2 |
| 9211072 | Kiani | Dec 2015 | B2 |
| 9211095 | Al-Ali | Dec 2015 | B1 |
| 9218454 | Kiani et al. | Dec 2015 | B2 |
| 9220440 | Addison et al. | Dec 2015 | B2 |
| 9226696 | Kiani | Jan 2016 | B2 |
| 9241662 | Al-Ali et al. | Jan 2016 | B2 |
| 9245668 | Vo et al. | Jan 2016 | B1 |
| 9259185 | Abdul-Hafiz et al. | Jan 2016 | B2 |
| 9267572 | Barker et al. | Feb 2016 | B2 |
| 9277880 | Poeze et al. | Feb 2016 | B2 |
| 9289167 | Diab et al. | Mar 2016 | B2 |
| 9295421 | Kiani et al. | Mar 2016 | B2 |
| 9307928 | Al-Ali et al. | Apr 2016 | B1 |
| 9323894 | Kiani | Apr 2016 | B2 |
| D755392 | Hwang et al. | May 2016 | S |
| 9326712 | Kiani | May 2016 | B1 |
| 9333316 | Kiani | May 2016 | B2 |
| 9339220 | Lamego et al. | May 2016 | B2 |
| 9341565 | Lamego et al. | May 2016 | B2 |
| 9351673 | Diab et al. | May 2016 | B2 |
| 9351675 | Al-Ali et al. | May 2016 | B2 |
| 9364181 | Kiani et al. | Jun 2016 | B2 |
| 9368671 | Wojtczuk et al. | Jun 2016 | B2 |
| 9370325 | Al-Ali et al. | Jun 2016 | B2 |
| 9370326 | McHale et al. | Jun 2016 | B2 |
| 9370335 | Al-ali et al. | Jun 2016 | B2 |
| 9375185 | Ali et al. | Jun 2016 | B2 |
| 9378637 | Kaib | Jun 2016 | B2 |
| 9386953 | Al-Ali | Jul 2016 | B2 |
| 9386961 | Al-Ali et al. | Jul 2016 | B2 |
| 9392945 | Al-Ali et al. | Jul 2016 | B2 |
| 9397448 | Al-Ali et al. | Jul 2016 | B2 |
| 9408542 | Kinast et al. | Aug 2016 | B1 |
| 9436645 | Al-Ali et al. | Sep 2016 | B2 |
| 9445759 | Lamego et al. | Sep 2016 | B1 |
| 9466919 | Kiani et al. | Oct 2016 | B2 |
| 9474474 | Lamego et al. | Oct 2016 | B2 |
| 9480422 | Al-Ali | Nov 2016 | B2 |
| 9480435 | Olsen | Nov 2016 | B2 |
| 9492110 | Al-Ali et al. | Nov 2016 | B2 |
| 9510779 | Poeze et al. | Dec 2016 | B2 |
| 9517024 | Kiani et al. | Dec 2016 | B2 |
| 9532722 | Lamego et al. | Jan 2017 | B2 |
| 9538949 | Al-Ali et al. | Jan 2017 | B2 |
| 9538980 | Telfort et al. | Jan 2017 | B2 |
| 9549696 | Lamego et al. | Jan 2017 | B2 |
| 9554737 | Schurman et al. | Jan 2017 | B2 |
| 9560996 | Kiani | Feb 2017 | B2 |
| 9560998 | Al-Ali et al. | Feb 2017 | B2 |
| 9566019 | Al-Ali et al. | Feb 2017 | B2 |
| 9579039 | Jansen et al. | Feb 2017 | B2 |
| 9591975 | Dalvi et al. | Mar 2017 | B2 |
| 9622692 | Lamego et al. | Apr 2017 | B2 |
| 9622693 | Diab | Apr 2017 | B2 |
| D788312 | Al-Ali et al. | May 2017 | S |
| 9636055 | Al-Ali et al. | May 2017 | B2 |
| 9636056 | Al-Ali | May 2017 | B2 |
| 9649054 | Lamego et al. | May 2017 | B2 |
| 9659475 | Kaib | May 2017 | B2 |
| 9662052 | Al-Ali et al. | May 2017 | B2 |
| 9668679 | Schurman et al. | Jun 2017 | B2 |
| 9668680 | Bruinsma et al. | Jun 2017 | B2 |
| 9668703 | Al-Ali | Jun 2017 | B2 |
| 9675286 | Diab | Jun 2017 | B2 |
| 9687160 | Kiani | Jun 2017 | B2 |
| 9693719 | Al-Ali et al. | Jul 2017 | B2 |
| 9693737 | Al-Ali | Jul 2017 | B2 |
| 9697928 | Al-Ali et al. | Jul 2017 | B2 |
| 9717425 | Kiani et al. | Aug 2017 | B2 |
| 9717458 | Lamego et al. | Aug 2017 | B2 |
| 9724016 | Al-Ali et al. | Aug 2017 | B1 |
| 9724024 | Al-Ali | Aug 2017 | B2 |
| 9724025 | Kiani et al. | Aug 2017 | B1 |
| 9730640 | Diab et al. | Aug 2017 | B2 |
| 9743887 | Al-Ali et al. | Aug 2017 | B2 |
| 9749232 | Sampath et al. | Aug 2017 | B2 |
| 9750442 | Olsen | Sep 2017 | B2 |
| 9750443 | Smith et al. | Sep 2017 | B2 |
| 9750461 | Telfort | Sep 2017 | B1 |
| 9775545 | Al-Ali et al. | Oct 2017 | B2 |
| 9775546 | Diab et al. | Oct 2017 | B2 |
| 9775570 | Al-Ali | Oct 2017 | B2 |
| 9778079 | Al-Ali et al. | Oct 2017 | B1 |
| 9782077 | Lamego et al. | Oct 2017 | B2 |
| 9782110 | Kiani | Oct 2017 | B2 |
| 9787568 | Lamego et al. | Oct 2017 | B2 |
| 9788735 | Al-Ali | Oct 2017 | B2 |
| 9788768 | Al-Ali et al. | Oct 2017 | B2 |
| 9795300 | Al-Ali | Oct 2017 | B2 |
| 9795310 | Al-Ali | Oct 2017 | B2 |
| 9795358 | Telfort et al. | Oct 2017 | B2 |
| 9795739 | Al-Ali et al. | Oct 2017 | B2 |
| 9801556 | Kiani | Oct 2017 | B2 |
| 9801588 | Weber et al. | Oct 2017 | B2 |
| 9808188 | Perea et al. | Nov 2017 | B1 |
| 9814418 | Weber et al. | Nov 2017 | B2 |
| 9820691 | Kiani | Nov 2017 | B2 |
| 9833152 | Kiani et al. | Dec 2017 | B2 |
| 9833180 | Shakespeare et al. | Dec 2017 | B2 |
| 9839379 | Al-Ali et al. | Dec 2017 | B2 |
| 9839381 | Weber et al. | Dec 2017 | B1 |
| 9847002 | Kiani et al. | Dec 2017 | B2 |
| 9847749 | Kiani et al. | Dec 2017 | B2 |
| 9848800 | Lee | Dec 2017 | B1 |
| 9848806 | Al-Ali et al. | Dec 2017 | B2 |
| 9848807 | Lamego | Dec 2017 | B2 |
| 9861298 | Eckerbom et al. | Jan 2018 | B2 |
| 9861304 | Al-Ali et al. | Jan 2018 | B2 |
| 9861305 | Weber et al. | Jan 2018 | B1 |
| 9867578 | Al-Ali et al. | Jan 2018 | B2 |
| 9872623 | Al-Ali | Jan 2018 | B2 |
| 9876320 | Coverston et al. | Jan 2018 | B2 |
| 9877650 | Muhsin et al. | Jan 2018 | B2 |
| 9877686 | Al-Ali et al. | Jan 2018 | B2 |
| 9891079 | Dalvi | Feb 2018 | B2 |
| 9895107 | Al-Ali et al. | Feb 2018 | B2 |
| 9924893 | Schurman et al. | Mar 2018 | B2 |
| 9924897 | Abdul-Hafiz | Mar 2018 | B1 |
| 9936917 | Poeze et al. | Apr 2018 | B2 |
| 9943269 | Muhsin et al. | Apr 2018 | B2 |
| 9949676 | Al-Ali | Apr 2018 | B2 |
| 9955937 | Telfort | May 2018 | B2 |
| 9965946 | Al-Ali | May 2018 | B2 |
| 9968266 | An et al. | May 2018 | B2 |
| 9980667 | Kiani et al. | May 2018 | B2 |
| D820865 | Muhsin et al. | Jun 2018 | S |
| 9986919 | Lamego et al. | Jun 2018 | B2 |
| 9986952 | Dalvi et al. | Jun 2018 | B2 |
| 9989560 | Poeze et al. | Jun 2018 | B2 |
| 9993207 | Al-Ali et al. | Jun 2018 | B2 |
| 10007758 | Al-Ali et al. | Jun 2018 | B2 |
| D822215 | Al-Ali et al. | Jul 2018 | S |
| D822216 | Barker et al. | Jul 2018 | S |
| 10010276 | Al-Ali et al. | Jul 2018 | B2 |
| 10032002 | Kiani et al. | Jul 2018 | B2 |
| 10039482 | Al-Ali et al. | Aug 2018 | B2 |
| 10052037 | Kinast et al. | Aug 2018 | B2 |
| 10058275 | Al-Ali et al. | Aug 2018 | B2 |
| 10064562 | Al-Ali | Sep 2018 | B2 |
| 10086138 | Novak, Jr. | Oct 2018 | B1 |
| 10092200 | Al-Ali et al. | Oct 2018 | B2 |
| 10092249 | Kiani et al. | Oct 2018 | B2 |
| 10098550 | Al-Ali et al. | Oct 2018 | B2 |
| 10098591 | Al-Ali et al. | Oct 2018 | B2 |
| 10098610 | Al-Ali et al. | Oct 2018 | B2 |
| 10111591 | Dyell et al. | Oct 2018 | B2 |
| D833624 | DeJong et al. | Nov 2018 | S |
| 10123726 | Al-Ali et al. | Nov 2018 | B2 |
| 10123729 | Dyell et al. | Nov 2018 | B2 |
| 10130289 | Al-Ali et al. | Nov 2018 | B2 |
| 10130291 | Schurman et al. | Nov 2018 | B2 |
| D835282 | Barker et al. | Dec 2018 | S |
| D835283 | Barker et al. | Dec 2018 | S |
| D835284 | Barker et al. | Dec 2018 | S |
| D835285 | Barker et al. | Dec 2018 | S |
| 10149616 | Al-Ali et al. | Dec 2018 | B2 |
| 10154815 | Al-Ali et al. | Dec 2018 | B2 |
| 10159412 | Lamego et al. | Dec 2018 | B2 |
| 10188296 | Al-Ali et al. | Jan 2019 | B2 |
| 10188331 | Al-Ali et al. | Jan 2019 | B1 |
| 10188348 | Kiani et al. | Jan 2019 | B2 |
| RE47218 | Al-Ali | Feb 2019 | E |
| RE47244 | Kiani et al. | Feb 2019 | E |
| RE47249 | Kiani et al. | Feb 2019 | E |
| 10194847 | Al-Ali | Feb 2019 | B2 |
| 10194848 | Kiani et al. | Feb 2019 | B1 |
| 10201298 | Al-Ali et al. | Feb 2019 | B2 |
| 10205272 | Kiani et al. | Feb 2019 | B2 |
| 10205291 | Scruggs et al. | Feb 2019 | B2 |
| 10213108 | Al-Ali | Feb 2019 | B2 |
| 10219706 | Al-Ali | Mar 2019 | B2 |
| 10219746 | McHale et al. | Mar 2019 | B2 |
| 10226187 | Al-Ali et al. | Mar 2019 | B2 |
| 10226576 | Kiani | Mar 2019 | B2 |
| 10231657 | Al-Ali et al. | Mar 2019 | B2 |
| 10231670 | Blank et al. | Mar 2019 | B2 |
| 10231676 | Al-Ali et al. | Mar 2019 | B2 |
| RE47353 | Kiani et al. | Apr 2019 | E |
| 10251585 | Al-Ali et al. | Apr 2019 | B2 |
| 10251586 | Lamego | Apr 2019 | B2 |
| 10255994 | Sampath et al. | Apr 2019 | B2 |
| 10258265 | Poeze et al. | Apr 2019 | B1 |
| 10258266 | Poeze et al. | Apr 2019 | B1 |
| 10271748 | Al-Ali | Apr 2019 | B2 |
| 10278626 | Schurman et al. | May 2019 | B2 |
| 10278648 | Al-Ali et al. | May 2019 | B2 |
| 10279247 | Kiani | May 2019 | B2 |
| 10292628 | Poeze et al. | May 2019 | B1 |
| 10292657 | Abdul-Hafiz et al. | May 2019 | B2 |
| 10292664 | Al-Ali | May 2019 | B2 |
| 10299708 | Poeze et al. | May 2019 | B1 |
| 10299709 | Perea et al. | May 2019 | B2 |
| 10299720 | Brown et al. | May 2019 | B2 |
| 10305775 | Lamego et al. | May 2019 | B2 |
| 10307111 | Muhsin et al. | Jun 2019 | B2 |
| 10325681 | Sampath et al. | Jun 2019 | B2 |
| 10327337 | Triman et al. | Jun 2019 | B2 |
| 10327713 | Barker et al. | Jun 2019 | B2 |
| 10332630 | Al-Ali | Jun 2019 | B2 |
| 10335033 | Al-Ali | Jul 2019 | B2 |
| 10335068 | Poeze et al. | Jul 2019 | B2 |
| 10335072 | Al-Ali et al. | Jul 2019 | B2 |
| 10342470 | Al-Ali et al. | Jul 2019 | B2 |
| 10342487 | Al-Ali et al. | Jul 2019 | B2 |
| 10342497 | Al-Ali et al. | Jul 2019 | B2 |
| 10349895 | Telfort et al. | Jul 2019 | B2 |
| 10349898 | Al-Ali et al. | Jul 2019 | B2 |
| 10354504 | Kiani et al. | Jul 2019 | B2 |
| 10357206 | Weber et al. | Jul 2019 | B2 |
| 10357209 | Al-Ali | Jul 2019 | B2 |
| 10366787 | Sampath et al. | Jul 2019 | B2 |
| 10368787 | Reichgott et al. | Aug 2019 | B2 |
| 10376190 | Poeze et al. | Aug 2019 | B1 |
| 10376191 | Poeze et al. | Aug 2019 | B1 |
| 10383520 | Wojtczuk et al. | Aug 2019 | B2 |
| 10383527 | Al-Ali | Aug 2019 | B2 |
| 10388120 | Muhsin et al. | Aug 2019 | B2 |
| D864120 | Forrest et al. | Oct 2019 | S |
| 10441181 | Telfort et al. | Oct 2019 | B1 |
| 10441196 | Eckerbom et al. | Oct 2019 | B2 |
| 10448844 | Al-Ali et al. | Oct 2019 | B2 |
| 10448871 | Al-Ali et al. | Oct 2019 | B2 |
| 10456038 | Lamego et al. | Oct 2019 | B2 |
| 10463340 | Telfort et al. | Nov 2019 | B2 |
| 10471159 | Lapotko et al. | Nov 2019 | B1 |
| 10505311 | Al-Ali et al. | Dec 2019 | B2 |
| 10524738 | Olsen | Jan 2020 | B2 |
| 10532174 | Al-Ali | Jan 2020 | B2 |
| 10537285 | Shreim et al. | Jan 2020 | B2 |
| 10542903 | Al-Ali et al. | Jan 2020 | B2 |
| 10555678 | Dalvi et al. | Feb 2020 | B2 |
| 10568553 | O'Neil et al. | Feb 2020 | B2 |
| 10608817 | Haider et al. | Mar 2020 | B2 |
| D880477 | Forrest et al. | Apr 2020 | S |
| 10617302 | Al-Ali et al. | Apr 2020 | B2 |
| 10617335 | Al-Ali et al. | Apr 2020 | B2 |
| 10637181 | Al-Ali et al. | Apr 2020 | B2 |
| D886849 | Muhsin et al. | Jun 2020 | S |
| D887548 | Abdul-Hafiz et al. | Jun 2020 | S |
| D887549 | Abdul-Hafiz et al. | Jun 2020 | S |
| 10667764 | Ahmed et al. | Jun 2020 | B2 |
| D890708 | Forrest et al. | Jul 2020 | S |
| 10721785 | Al-Ali | Jul 2020 | B2 |
| 10736518 | Al-Ali et al. | Aug 2020 | B2 |
| 10750984 | Pauley et al. | Aug 2020 | B2 |
| D897098 | Al-Ali | Sep 2020 | S |
| 10779098 | Iswanto et al. | Sep 2020 | B2 |
| 10827961 | Iyengar et al. | Nov 2020 | B1 |
| 10828007 | Telfort et al. | Nov 2020 | B1 |
| 10832818 | Muhsin et al. | Nov 2020 | B2 |
| 10849554 | Shreim et al. | Dec 2020 | B2 |
| 10856750 | Indorf | Dec 2020 | B2 |
| D906970 | Forrest et al. | Jan 2021 | S |
| D908213 | Abdul-Hafiz et al. | Jan 2021 | S |
| 10918281 | Al-Ali et al. | Feb 2021 | B2 |
| 10932705 | Muhsin et al. | Mar 2021 | B2 |
| 10932729 | Kiani et al. | Mar 2021 | B2 |
| 10939878 | Kiani et al. | Mar 2021 | B2 |
| 10956950 | Al-Ali et al. | Mar 2021 | B2 |
| D916135 | Indorf et al. | Apr 2021 | S |
| D917046 | Abdul-Hafiz et al. | Apr 2021 | S |
| D917550 | Indorf et al. | Apr 2021 | S |
| D917564 | Indorf et al. | Apr 2021 | S |
| D917704 | Al-Ali et al. | Apr 2021 | S |
| 10987066 | Chandran et al. | Apr 2021 | B2 |
| 10991135 | Al-Ali et al. | Apr 2021 | B2 |
| D919094 | Al-Ali et al. | May 2021 | S |
| D919100 | Al-Ali et al. | May 2021 | S |
| 11006867 | Ai-Ali | May 2021 | B2 |
| D921202 | Al-Ali et al. | Jun 2021 | S |
| 11024064 | Muhsin et al. | Jun 2021 | B2 |
| 11026604 | Chen et al. | Jun 2021 | B2 |
| D925597 | Chandran et al. | Jul 2021 | S |
| D927699 | Al-Ali et al. | Aug 2021 | S |
| 11076777 | Lee et al. | Aug 2021 | B2 |
| 11114188 | Poeze et al. | Sep 2021 | B2 |
| D933232 | Al-Ali et al. | Oct 2021 | S |
| D933233 | Al-Ali et al. | Oct 2021 | S |
| D933234 | Al-Ali et al. | Oct 2021 | S |
| 11145408 | Sampath et al. | Oct 2021 | B2 |
| 11147518 | Al-Ali et al. | Oct 2021 | B1 |
| 11185262 | Al-Ali et al. | Nov 2021 | B2 |
| 11191484 | Kiani et al. | Dec 2021 | B2 |
| D946596 | Ahmed | Mar 2022 | S |
| D946597 | Ahmed | Mar 2022 | S |
| D946598 | Ahmed | Mar 2022 | S |
| D946617 | Ahmed | Mar 2022 | S |
| 11272839 | Al-Ali et al. | Mar 2022 | B2 |
| 11289199 | Al-Ali | Mar 2022 | B2 |
| RE49034 | Al-Ali | Apr 2022 | E |
| 11298021 | Muhsin et al. | Apr 2022 | B2 |
| D950580 | Ahmed | May 2022 | S |
| D950599 | Ahmed | May 2022 | S |
| D950738 | Al-Ali et al. | May 2022 | S |
| D957648 | Al-Ali | Jul 2022 | S |
| 11382567 | O'Brien et al. | Jul 2022 | B2 |
| 11389093 | Triman et al. | Jul 2022 | B2 |
| 11406286 | Al-Ali et al. | Aug 2022 | B2 |
| 11417426 | Muhsin et al. | Aug 2022 | B2 |
| 11439329 | Lamego | Sep 2022 | B2 |
| 11445948 | Scruggs et al. | Sep 2022 | B2 |
| D965789 | Al-Ali et al. | Oct 2022 | S |
| D967433 | Al-Ali et al. | Oct 2022 | S |
| 11464410 | Muhsin | Oct 2022 | B2 |
| 11504058 | Sharma et al. | Nov 2022 | B1 |
| 11504066 | Dalvi et al. | Nov 2022 | B1 |
| D971933 | Ahmed | Dec 2022 | S |
| D973072 | Ahmed | Dec 2022 | S |
| D973685 | Ahmed | Dec 2022 | S |
| D973686 | Ahmed | Dec 2022 | S |
| D974193 | Forrest et al. | Jan 2023 | S |
| D979516 | Al-Ali et al. | Feb 2023 | S |
| D980091 | Forrest et al. | Mar 2023 | S |
| 11596363 | Lamego | Mar 2023 | B2 |
| 11627919 | Kiani et al. | Apr 2023 | B2 |
| 11637437 | Al-Ali et al. | Apr 2023 | B2 |
| D985498 | Al-Ali et al. | May 2023 | S |
| 11653862 | Dalvi et al. | May 2023 | B2 |
| D989112 | Muhsin et al. | Jun 2023 | S |
| D989327 | Al-Ali et al. | Jun 2023 | S |
| 11678829 | Al-Ali et al. | Jun 2023 | B2 |
| 11679579 | Al-Ali | Jun 2023 | B2 |
| 11684296 | Vo et al. | Jun 2023 | B2 |
| 11692934 | Normand et al. | Jul 2023 | B2 |
| 11701043 | Al-Ali et al. | Jul 2023 | B2 |
| D997365 | Hwang | Aug 2023 | S |
| 11721105 | Ranasinghe et al. | Aug 2023 | B2 |
| 11730379 | Ahmed et al. | Aug 2023 | B2 |
| D998625 | Indorf et al. | Sep 2023 | S |
| D998630 | Indorf et al. | Sep 2023 | S |
| D998631 | Indorf et al. | Sep 2023 | S |
| 11766198 | Pauley et al. | Sep 2023 | B2 |
| D1000975 | Al-Ali et al. | Oct 2023 | S |
| 20010002206 | Diab et al. | May 2001 | A1 |
| 20010034477 | Mansfield et al. | Oct 2001 | A1 |
| 20010039483 | Brand et al. | Nov 2001 | A1 |
| 20020010401 | Bushmakin et al. | Jan 2002 | A1 |
| 20020058864 | Mansfield et al. | May 2002 | A1 |
| 20020133080 | Apruzzese et al. | Sep 2002 | A1 |
| 20020193670 | Garfield et al. | Dec 2002 | A1 |
| 20030013975 | Kiani | Jan 2003 | A1 |
| 20030015368 | Cybulski et al. | Jan 2003 | A1 |
| 20030018243 | Gerhardt et al. | Jan 2003 | A1 |
| 20030065269 | Vetter | Apr 2003 | A1 |
| 20030076494 | Bonin et al. | Apr 2003 | A1 |
| 20030144582 | Cohen et al. | Jul 2003 | A1 |
| 20030156288 | Barnum et al. | Aug 2003 | A1 |
| 20030158466 | Lynn et al. | Aug 2003 | A1 |
| 20030163033 | Dekker et al. | Aug 2003 | A1 |
| 20030163054 | Dekker | Aug 2003 | A1 |
| 20030212312 | Coffin, IV et al. | Nov 2003 | A1 |
| 20040010202 | Nakatani | Jan 2004 | A1 |
| 20040059203 | Guerrero | Mar 2004 | A1 |
| 20040060362 | Kjellmann et al. | Apr 2004 | A1 |
| 20040106163 | Workman, Jr. et al. | Jun 2004 | A1 |
| 20040133087 | Ali et al. | Jul 2004 | A1 |
| 20040158162 | Narimatsu | Aug 2004 | A1 |
| 20040225332 | Gebhardt | Nov 2004 | A1 |
| 20040260186 | Dekker | Dec 2004 | A1 |
| 20050027205 | Tarassenko et al. | Feb 2005 | A1 |
| 20050048456 | Chefd'hotel et al. | Mar 2005 | A1 |
| 20050055276 | Kiani et al. | Mar 2005 | A1 |
| 20050070774 | Addison et al. | Mar 2005 | A1 |
| 20050107699 | Loftman | May 2005 | A1 |
| 20050116820 | Goldreich | Jun 2005 | A1 |
| 20050199056 | Strong | Sep 2005 | A1 |
| 20050234317 | Kiani | Oct 2005 | A1 |
| 20060047215 | Newman et al. | Mar 2006 | A1 |
| 20060073719 | Kiani | Apr 2006 | A1 |
| 20060129216 | Hastings et al. | Jun 2006 | A1 |
| 20060149144 | Lynn et al. | Jul 2006 | A1 |
| 20060155206 | Lynn | Jul 2006 | A1 |
| 20060155207 | Lynn et al. | Jul 2006 | A1 |
| 20060161071 | Lynn et al. | Jul 2006 | A1 |
| 20060189871 | Al-Ali et al. | Aug 2006 | A1 |
| 20060189880 | Lynn et al. | Aug 2006 | A1 |
| 20060195041 | Lynn et al. | Aug 2006 | A1 |
| 20060235324 | Lynn | Oct 2006 | A1 |
| 20060238333 | Welch et al. | Oct 2006 | A1 |
| 20060241510 | Halperin et al. | Oct 2006 | A1 |
| 20060258921 | Addison et al. | Nov 2006 | A1 |
| 20070073116 | Kiani et al. | Mar 2007 | A1 |
| 20070093721 | Lynn et al. | Apr 2007 | A1 |
| 20070129643 | Kwok et al. | Jun 2007 | A1 |
| 20070129647 | Lynn | Jun 2007 | A1 |
| 20070135725 | Hatlestad | Jun 2007 | A1 |
| 20070149860 | Lynn et al. | Jun 2007 | A1 |
| 20070163353 | Lec et al. | Jul 2007 | A1 |
| 20070180140 | Welch et al. | Aug 2007 | A1 |
| 20070185397 | Govari et al. | Aug 2007 | A1 |
| 20070213619 | Linder | Sep 2007 | A1 |
| 20070239057 | Pu et al. | Oct 2007 | A1 |
| 20070244377 | Cozad et al. | Oct 2007 | A1 |
| 20070282212 | Sierra et al. | Dec 2007 | A1 |
| 20070282478 | Al-Ali et al. | Dec 2007 | A1 |
| 20080013747 | Tran | Jan 2008 | A1 |
| 20080039735 | Hickerson | Feb 2008 | A1 |
| 20080064965 | Jay et al. | Mar 2008 | A1 |
| 20080071185 | Beck et al. | Mar 2008 | A1 |
| 20080076972 | Dorogusker et al. | Mar 2008 | A1 |
| 20080094228 | Welch et al. | Apr 2008 | A1 |
| 20080103375 | Kiani | May 2008 | A1 |
| 20080119716 | Boric-Lubecke et al. | May 2008 | A1 |
| 20080161878 | Tehrani et al. | Jul 2008 | A1 |
| 20080177195 | Armitstead | Jul 2008 | A1 |
| 20080188733 | Al-Ali | Aug 2008 | A1 |
| 20080188760 | Al-Ali | Aug 2008 | A1 |
| 20080218153 | Patel et al. | Sep 2008 | A1 |
| 20080221418 | Al-Ali et al. | Sep 2008 | A1 |
| 20080275349 | Halperin et al. | Nov 2008 | A1 |
| 20080304580 | Ichiyama | Dec 2008 | A1 |
| 20090018409 | Banet | Jan 2009 | A1 |
| 20090018429 | Saliga et al. | Jan 2009 | A1 |
| 20090018453 | Banet et al. | Jan 2009 | A1 |
| 20090036759 | Ault et al. | Feb 2009 | A1 |
| 20090093687 | Telfort et al. | Apr 2009 | A1 |
| 20090095926 | MacNeish, III | Apr 2009 | A1 |
| 20090112096 | Tamura | Apr 2009 | A1 |
| 20090160654 | Yang | Jun 2009 | A1 |
| 20090167332 | Forbes | Jul 2009 | A1 |
| 20090187065 | Basinger | Jul 2009 | A1 |
| 20090227882 | Foo | Sep 2009 | A1 |
| 20090240119 | Schwaibold et al. | Sep 2009 | A1 |
| 20090247848 | Baker | Oct 2009 | A1 |
| 20090247984 | Lamego et al. | Oct 2009 | A1 |
| 20090275844 | Al-Ali | Nov 2009 | A1 |
| 20090299157 | Telfort et al. | Dec 2009 | A1 |
| 20090312612 | Rantala | Dec 2009 | A1 |
| 20100004518 | Vo et al. | Jan 2010 | A1 |
| 20100004552 | Zhang et al. | Jan 2010 | A1 |
| 20100014761 | Addison et al. | Jan 2010 | A1 |
| 20100016682 | Schluess et al. | Jan 2010 | A1 |
| 20100016693 | Addison | Jan 2010 | A1 |
| 20100030040 | Poeze et al. | Feb 2010 | A1 |
| 20100099964 | O'Reilly et al. | Apr 2010 | A1 |
| 20100130873 | Yuen | May 2010 | A1 |
| 20100204550 | Heneghan | Aug 2010 | A1 |
| 20100234718 | Sampath et al. | Sep 2010 | A1 |
| 20100261979 | Kiani | Oct 2010 | A1 |
| 20100270257 | Wachman et al. | Oct 2010 | A1 |
| 20100274099 | Telfort et al. | Oct 2010 | A1 |
| 20100295686 | Sloan | Nov 2010 | A1 |
| 20100298661 | McCombie et al. | Nov 2010 | A1 |
| 20100298730 | Taressenko et al. | Nov 2010 | A1 |
| 20100324377 | Woehrle | Dec 2010 | A1 |
| 20100331903 | Zhang | Dec 2010 | A1 |
| 20110001605 | Kiani | Jan 2011 | A1 |
| 20110009710 | Kroeger et al. | Jan 2011 | A1 |
| 20110028806 | Merritt et al. | Feb 2011 | A1 |
| 20110028809 | Goodman | Feb 2011 | A1 |
| 20110040197 | Welch et al. | Feb 2011 | A1 |
| 20110040713 | Colman | Feb 2011 | A1 |
| 20110066062 | Banet et al. | Mar 2011 | A1 |
| 20110074409 | Stoughton | Mar 2011 | A1 |
| 20110082711 | Poeze et al. | Apr 2011 | A1 |
| 20110087081 | Kiani et al. | Apr 2011 | A1 |
| 20110105854 | Kiani et al. | May 2011 | A1 |
| 20110118561 | Tari et al. | May 2011 | A1 |
| 20110118573 | McKenna | May 2011 | A1 |
| 20110125060 | Telfort et al. | May 2011 | A1 |
| 20110137297 | Kiani et al. | Jun 2011 | A1 |
| 20110172498 | Olsen et al. | Jul 2011 | A1 |
| 20110172561 | Kiani et al. | Jul 2011 | A1 |
| 20110208015 | Welch et al. | Aug 2011 | A1 |
| 20110209915 | Telfort et al. | Sep 2011 | A1 |
| 20110213212 | Al-Ali | Sep 2011 | A1 |
| 20110222371 | Liu et al. | Sep 2011 | A1 |
| 20110230733 | Al-Ali et al. | Sep 2011 | A1 |
| 20110237911 | Lamego et al. | Sep 2011 | A1 |
| 20120016255 | Masuo | Jan 2012 | A1 |
| 20120059267 | Lamego et al. | Mar 2012 | A1 |
| 20120070013 | Vau | Mar 2012 | A1 |
| 20120101344 | Desjardins | Apr 2012 | A1 |
| 20120116175 | Al-Ali et al. | May 2012 | A1 |
| 20120123231 | O'Reilly | May 2012 | A1 |
| 20120165629 | Merritt et al. | Jun 2012 | A1 |
| 20120179006 | Jansen et al. | Jul 2012 | A1 |
| 20120209082 | Al-Ali | Aug 2012 | A1 |
| 20120209084 | Olsen et al. | Aug 2012 | A1 |
| 20120226117 | Lamego et al. | Sep 2012 | A1 |
| 20120227739 | Kiani | Sep 2012 | A1 |
| 20120253140 | Addison et al. | Oct 2012 | A1 |
| 20120262298 | Bohm | Oct 2012 | A1 |
| 20120283524 | Kiani et al. | Nov 2012 | A1 |
| 20120296178 | Lamego et al. | Nov 2012 | A1 |
| 20120319816 | Al-Ali | Dec 2012 | A1 |
| 20120330112 | Lamego et al. | Dec 2012 | A1 |
| 20130023775 | Lamego et al. | Jan 2013 | A1 |
| 20130045685 | Kiani | Feb 2013 | A1 |
| 20130046204 | Lamego | Feb 2013 | A1 |
| 20130041591 | Lamego | Mar 2013 | A1 |
| 20130060147 | Welch et al. | Mar 2013 | A1 |
| 20130096405 | Garfio | Apr 2013 | A1 |
| 20130096936 | Sampath et al. | Apr 2013 | A1 |
| 20130109935 | Al-Ali et al. | May 2013 | A1 |
| 20130116578 | An et al. | May 2013 | A1 |
| 20130128690 | Gopalan | May 2013 | A1 |
| 20130137936 | Baker, Jr. et al. | May 2013 | A1 |
| 20130162433 | Muhsin et al. | Jun 2013 | A1 |
| 20130190581 | Al-Ali et al. | Jul 2013 | A1 |
| 20130190595 | Oraevsky | Jul 2013 | A1 |
| 20130197328 | Diab et al. | Aug 2013 | A1 |
| 20130243021 | Siskavich | Sep 2013 | A1 |
| 20130253334 | Al-Ali et al. | Sep 2013 | A1 |
| 20130274571 | Diab et al. | Oct 2013 | A1 |
| 20130296672 | Dalvi et al. | Nov 2013 | A1 |
| 20130296713 | Al-Ali et al. | Nov 2013 | A1 |
| 20130296726 | Nievauer et al. | Nov 2013 | A1 |
| 20130317370 | Dalvi et al. | Nov 2013 | A1 |
| 20130324808 | Al-Ali et al. | Dec 2013 | A1 |
| 20130331670 | Kiani | Dec 2013 | A1 |
| 20130338461 | Lamego et al. | Dec 2013 | A1 |
| 20130345921 | Al-Ali et al. | Dec 2013 | A1 |
| 20140012100 | Lamego et al. | Jan 2014 | A1 |
| 20140025306 | Weber et al. | Jan 2014 | A1 |
| 20140034353 | Al-Ali et al. | Feb 2014 | A1 |
| 20140051953 | Lamego et al. | Feb 2014 | A1 |
| 20140058230 | Abdul-Hafiz et al. | Feb 2014 | A1 |
| 20140066783 | Kiani et al. | Mar 2014 | A1 |
| 20140077956 | Sampath et al. | Mar 2014 | A1 |
| 20140081100 | Muhsin et al. | Mar 2014 | A1 |
| 20140081175 | Telfort | Mar 2014 | A1 |
| 20140094667 | Schurman et al. | Apr 2014 | A1 |
| 20140100434 | Diab et al. | Apr 2014 | A1 |
| 20140114199 | Lamego et al. | Apr 2014 | A1 |
| 20140120564 | Workman et al. | May 2014 | A1 |
| 20140121482 | Merritt et al. | May 2014 | A1 |
| 20140121483 | Kiani | May 2014 | A1 |
| 20140127137 | Bellott et al. | May 2014 | A1 |
| 20140128696 | Al-Ali | May 2014 | A1 |
| 20140128699 | Al-Ali et al. | May 2014 | A1 |
| 20140129702 | Lamego et al. | May 2014 | A1 |
| 20140135588 | Al-Ali et al. | May 2014 | A1 |
| 20140142401 | Al-Ali et al. | May 2014 | A1 |
| 20140142402 | Al-Ali et al. | May 2014 | A1 |
| 20140163344 | Al-Ali | Jun 2014 | A1 |
| 20140163402 | Lamego et al. | Jun 2014 | A1 |
| 20140166076 | Kiani et al. | Jun 2014 | A1 |
| 20140171763 | Diab | Jun 2014 | A1 |
| 20140180038 | Kiani et al. | Jun 2014 | A1 |
| 20140180154 | Sierra et al. | Jun 2014 | A1 |
| 20140180160 | Brown et al. | Jun 2014 | A1 |
| 20140187973 | Brown et al. | Jul 2014 | A1 |
| 20140194709 | Al-Ali et al. | Jul 2014 | A1 |
| 20140194711 | Al-Ali | Jul 2014 | A1 |
| 20140194766 | Al-Ali et al. | Jul 2014 | A1 |
| 20140206963 | Diab et al. | Jul 2014 | A1 |
| 20140213864 | Abdul-Hafiz et al. | Jul 2014 | A1 |
| 20140243627 | Diab et al. | Aug 2014 | A1 |
| 20140266790 | Al-Ali et al. | Sep 2014 | A1 |
| 20140275808 | Poeze et al. | Sep 2014 | A1 |
| 20140275835 | Lamego et al. | Sep 2014 | A1 |
| 20140275871 | Lamego et al. | Sep 2014 | A1 |
| 20140275872 | Merritt et al. | Sep 2014 | A1 |
| 20140275881 | Lamego et al. | Sep 2014 | A1 |
| 20140288400 | Diab et al. | Sep 2014 | A1 |
| 20140296664 | Bruinsma et al. | Oct 2014 | A1 |
| 20140303520 | Telfort et al. | Oct 2014 | A1 |
| 20140309506 | Lamego et al. | Oct 2014 | A1 |
| 20140316217 | Purdon et al. | Oct 2014 | A1 |
| 20140316218 | Purdon et al. | Oct 2014 | A1 |
| 20140316228 | Blank et al. | Oct 2014 | A1 |
| 20140323825 | Al-Ali et al. | Oct 2014 | A1 |
| 20140323897 | Brown et al. | Oct 2014 | A1 |
| 20140323898 | Purdon et al. | Oct 2014 | A1 |
| 20140330092 | Al-Ali et al. | Nov 2014 | A1 |
| 20140330098 | Merritt et al. | Nov 2014 | A1 |
| 20140330099 | Al-Ali et al. | Nov 2014 | A1 |
| 20140333440 | Kiani | Nov 2014 | A1 |
| 20140336481 | Shakespeare et al. | Nov 2014 | A1 |
| 20140343436 | Kiani | Nov 2014 | A1 |
| 20140357966 | Al-Ali et al. | Dec 2014 | A1 |
| 20150005600 | Blank et al. | Jan 2015 | A1 |
| 20150011907 | Purdon et al. | Jan 2015 | A1 |
| 20150012231 | Poeze et al. | Jan 2015 | A1 |
| 20150018650 | Al-Ali et al. | Jan 2015 | A1 |
| 20150032029 | Al-Ali et al. | Jan 2015 | A1 |
| 20150038859 | Dalvi et al. | Feb 2015 | A1 |
| 20150073241 | Lamego | Mar 2015 | A1 |
| 20150080754 | Purdon et al. | Mar 2015 | A1 |
| 20150087936 | Al-Ali et al. | Mar 2015 | A1 |
| 20150094546 | Al-Ali | Apr 2015 | A1 |
| 20150097701 | Al-Ali et al. | Apr 2015 | A1 |
| 20150099950 | Al-Ali et al. | Apr 2015 | A1 |
| 20150099955 | Al-Ali et al. | Apr 2015 | A1 |
| 20150101844 | Al-Ali et al. | Apr 2015 | A1 |
| 20150106121 | Muhsin et al. | Apr 2015 | A1 |
| 20150112151 | Muhsin et al. | Apr 2015 | A1 |
| 20150116076 | Al-Ali et al. | Apr 2015 | A1 |
| 20150165312 | Kiani | Jun 2015 | A1 |
| 20150196249 | Brown et al. | Jul 2015 | A1 |
| 20150216459 | Al-Ali et al. | Aug 2015 | A1 |
| 20150238722 | Al-Ali | Aug 2015 | A1 |
| 20150245773 | Lamego et al. | Sep 2015 | A1 |
| 20150245794 | Al-Ali | Sep 2015 | A1 |
| 20150257689 | Al-Ali et al. | Sep 2015 | A1 |
| 20150272514 | Kiani et al. | Oct 2015 | A1 |
| 20150351697 | Weber et al. | Dec 2015 | A1 |
| 20150359429 | Al-Ali et al. | Dec 2015 | A1 |
| 20150366507 | Blank | Dec 2015 | A1 |
| 20160029932 | Al-Ali | Feb 2016 | A1 |
| 20160058347 | Reichgott et al. | Mar 2016 | A1 |
| 20160066824 | Al-Ali et al. | Mar 2016 | A1 |
| 20160081552 | Wojtczuk et al. | Mar 2016 | A1 |
| 20160095543 | Telfort et al. | Apr 2016 | A1 |
| 20160095548 | Al-Ali et al. | Apr 2016 | A1 |
| 20160103598 | Al-Ali et al. | Apr 2016 | A1 |
| 20160143548 | Al-Ali | May 2016 | A1 |
| 20160166182 | Al-Ali et al. | Jun 2016 | A1 |
| 20160166183 | Poeze et al. | Jun 2016 | A1 |
| 20160192869 | Kiani et al. | Jul 2016 | A1 |
| 20160196388 | Lamego | Jul 2016 | A1 |
| 20160197436 | Barker et al. | Jul 2016 | A1 |
| 20160213281 | Eckerbom et al. | Jul 2016 | A1 |
| 20160228043 | O'Neil et al. | Aug 2016 | A1 |
| 20160233632 | Scruggs et al. | Aug 2016 | A1 |
| 20160234944 | Schmidt et al. | Aug 2016 | A1 |
| 20160270735 | Diab et al. | Sep 2016 | A1 |
| 20160283665 | Sampath et al. | Sep 2016 | A1 |
| 20160287090 | Al-Ali et al. | Oct 2016 | A1 |
| 20160287786 | Kiani | Oct 2016 | A1 |
| 20160296169 | McHale et al. | Oct 2016 | A1 |
| 20160310052 | Al-Ali et al. | Oct 2016 | A1 |
| 20160314260 | Kiani | Oct 2016 | A1 |
| 20160324486 | Al-Ali et al. | Nov 2016 | A1 |
| 20160324488 | Olsen | Nov 2016 | A1 |
| 20160327984 | Al-Ali et al. | Nov 2016 | A1 |
| 20160328528 | Al-Ali et al. | Nov 2016 | A1 |
| 20160331332 | Al-Ali | Nov 2016 | A1 |
| 20160367173 | Dalvi et al. | Dec 2016 | A1 |
| 20170000394 | Al-Ali et al. | Jan 2017 | A1 |
| 20170007134 | Al-Ali et al. | Jan 2017 | A1 |
| 20170007198 | Al-Ali et al. | Jan 2017 | A1 |
| 20170014083 | Diab et al. | Jan 2017 | A1 |
| 20170014084 | Al-Ali et al. | Jan 2017 | A1 |
| 20170024748 | Haider | Jan 2017 | A1 |
| 20170027456 | Kinast et al. | Feb 2017 | A1 |
| 20170042488 | Muhsin | Feb 2017 | A1 |
| 20170055851 | Al-Ali | Mar 2017 | A1 |
| 20170055882 | Al-Ali et al. | Mar 2017 | A1 |
| 20170055887 | Al-Ali | Mar 2017 | A1 |
| 20170055896 | Al-Ali et al. | Mar 2017 | A1 |
| 20170079594 | Telfort et al. | Mar 2017 | A1 |
| 20170086723 | Al-Ali et al. | Mar 2017 | A1 |
| 20170143281 | Olsen | May 2017 | A1 |
| 20170147774 | Kiani | May 2017 | A1 |
| 20170156620 | Al-Ali et al. | Jun 2017 | A1 |
| 20170173632 | Al-Ali | Jun 2017 | A1 |
| 20170187146 | Kiani et al. | Jun 2017 | A1 |
| 20170188919 | Al-Ali et al. | Jul 2017 | A1 |
| 20170196464 | Jansen et al. | Jul 2017 | A1 |
| 20170196470 | Lamego et al. | Jul 2017 | A1 |
| 20170202490 | Al-Ali et al. | Jul 2017 | A1 |
| 20170224262 | Al-Ali | Aug 2017 | A1 |
| 20170228516 | Sampath et al. | Aug 2017 | A1 |
| 20170245790 | Al-Ali et al. | Aug 2017 | A1 |
| 20170251974 | Shreim et al. | Sep 2017 | A1 |
| 20170251975 | Shreim et al. | Sep 2017 | A1 |
| 20170258403 | Abdul-Hafiz et al. | Sep 2017 | A1 |
| 20170311851 | Schurman et al. | Nov 2017 | A1 |
| 20170311891 | Kiani et al. | Nov 2017 | A1 |
| 20170325728 | Al-Ali et al. | Nov 2017 | A1 |
| 20170332976 | Al-Ali et al. | Nov 2017 | A1 |
| 20170340293 | Al-Ali et al. | Nov 2017 | A1 |
| 20170360310 | Kiani et al. | Dec 2017 | A1 |
| 20170367632 | Al-Ali et al. | Dec 2017 | A1 |
| 20180008146 | Al-Ali et al. | Jan 2018 | A1 |
| 20180014752 | Al-Ali et al. | Jan 2018 | A1 |
| 20180028124 | Al-Ali et al. | Feb 2018 | A1 |
| 20180055385 | Al-Ali | Mar 2018 | A1 |
| 20180055390 | Kiani et al. | Mar 2018 | A1 |
| 20180055430 | Diab et al. | Mar 2018 | A1 |
| 20180064381 | Shakespeare et al. | Mar 2018 | A1 |
| 20180069776 | Lamego et al. | Mar 2018 | A1 |
| 20180103874 | Lee et al. | Apr 2018 | A1 |
| 20180110478 | Al-Ali | Apr 2018 | A1 |
| 20180116575 | Perea et al. | May 2018 | A1 |
| 20180125368 | Lamego et al. | May 2018 | A1 |
| 20180125430 | Al-Ali et al. | May 2018 | A1 |
| 20180130325 | Kiani et al. | May 2018 | A1 |
| 20180132769 | Weber et al. | May 2018 | A1 |
| 20180132770 | Lamego | May 2018 | A1 |
| 20180146901 | Al-Ali et al. | May 2018 | A1 |
| 20180146902 | Kiani et al. | May 2018 | A1 |
| 20180153442 | Eckerbom et al. | Jun 2018 | A1 |
| 20180153446 | Kiani | Jun 2018 | A1 |
| 20180153447 | Al-Ali et al. | Jun 2018 | A1 |
| 20180153448 | Weber et al. | Jun 2018 | A1 |
| 20180161499 | Al-Ali et al. | Jun 2018 | A1 |
| 20180168491 | Al-Ali et al. | Jun 2018 | A1 |
| 20180174679 | Sampath et al. | Jun 2018 | A1 |
| 20180174680 | Sampath et al. | Jun 2018 | A1 |
| 20180182484 | Sampath et al. | Jun 2018 | A1 |
| 20180184917 | Kiani | Jul 2018 | A1 |
| 20180192953 | Shreim et al. | Jul 2018 | A1 |
| 20180192955 | Al-Ali et al. | Jul 2018 | A1 |
| 20180199871 | Pauley et al. | Jul 2018 | A1 |
| 20180206795 | Al-Ali | Jul 2018 | A1 |
| 20180206815 | Telfort | Jul 2018 | A1 |
| 20180213583 | Al-Ali | Jul 2018 | A1 |
| 20180214031 | Kiani et al. | Aug 2018 | A1 |
| 20180214090 | Al-Ali et al. | Aug 2018 | A1 |
| 20180216370 | Ishiguro et al. | Aug 2018 | A1 |
| 20180218792 | Muhsin et al. | Aug 2018 | A1 |
| 20180225960 | Al-Ali et al. | Aug 2018 | A1 |
| 20180238718 | Dalvi | Aug 2018 | A1 |
| 20180242853 | Al-Ali | Aug 2018 | A1 |
| 20180242921 | Muhsin et al. | Aug 2018 | A1 |
| 20180242923 | Al-Ali et al. | Aug 2018 | A1 |
| 20180242924 | Barker et al. | Aug 2018 | A1 |
| 20180242926 | Muhsin et al. | Aug 2018 | A1 |
| 20180247353 | Al-Ali et al. | Aug 2018 | A1 |
| 20180247712 | Muhsin et al. | Aug 2018 | A1 |
| 20180249933 | Schurman et al. | Sep 2018 | A1 |
| 20180253947 | Muhsin et al. | Sep 2018 | A1 |
| 20180256087 | Al-Ali et al. | Sep 2018 | A1 |
| 20180256113 | Weber et al. | Sep 2018 | A1 |
| 20180285094 | Housel et al. | Oct 2018 | A1 |
| 20180289325 | Poeze et al. | Oct 2018 | A1 |
| 20180289337 | Al-Ali et al. | Oct 2018 | A1 |
| 20180296161 | Shreim et al. | Oct 2018 | A1 |
| 20180300919 | Muhsin et al. | Oct 2018 | A1 |
| 20180310822 | Indorf et al. | Nov 2018 | A1 |
| 20180310823 | Al-Ali et al. | Nov 2018 | A1 |
| 20180317826 | Muhsin | Nov 2018 | A1 |
| 20180317841 | Novak, Jr. | Nov 2018 | A1 |
| 20180333055 | Lamego et al. | Nov 2018 | A1 |
| 20180333087 | Al-Ali | Nov 2018 | A1 |
| 20190000317 | Muhsin et al. | Jan 2019 | A1 |
| 20190000362 | Kiani et al. | Jan 2019 | A1 |
| 20190015023 | Monfre | Jan 2019 | A1 |
| 20190021638 | Al-Ali et al. | Jan 2019 | A1 |
| 20190029574 | Schurman et al. | Jan 2019 | A1 |
| 20190029578 | Al-Ali et al. | Jan 2019 | A1 |
| 20190038143 | Al-Ali | Feb 2019 | A1 |
| 20190058280 | Al-Ali et al. | Feb 2019 | A1 |
| 20190058281 | Al-Ali et al. | Feb 2019 | A1 |
| 20190069813 | Al-Ali | Mar 2019 | A1 |
| 20190069814 | Al-Ali | Mar 2019 | A1 |
| 20190076028 | Al-Ali et al. | Mar 2019 | A1 |
| 20190082979 | Al-Ali et al. | Mar 2019 | A1 |
| 20190090748 | Al-Ali | Mar 2019 | A1 |
| 20190090760 | Kinast et al. | Mar 2019 | A1 |
| 20190090764 | Al-Ali | Mar 2019 | A1 |
| 20190104973 | Poeze et al. | Apr 2019 | A1 |
| 20190110719 | Poeze et al. | Apr 2019 | A1 |
| 20190117070 | Muhsin et al. | Apr 2019 | A1 |
| 20190117139 | Al-Ali et al. | Apr 2019 | A1 |
| 20190117140 | Al-Ali et al. | Apr 2019 | A1 |
| 20190117141 | Al-Ali | Apr 2019 | A1 |
| 20190117930 | Al-Ali | Apr 2019 | A1 |
| 20190122763 | Sampath et al. | Apr 2019 | A1 |
| 20190133525 | Al-Ali et al. | May 2019 | A1 |
| 20190142283 | Lamego et al. | May 2019 | A1 |
| 20190142344 | Telfort et al. | May 2019 | A1 |
| 20190150800 | Poeze et al. | May 2019 | A1 |
| 20190150856 | Kiani et al. | May 2019 | A1 |
| 20190167161 | Al-Ali et al. | Jun 2019 | A1 |
| 20190175019 | Al-Ali et al. | Jun 2019 | A1 |
| 20190192076 | McHale et al. | Jun 2019 | A1 |
| 20190200941 | Chandran et al. | Jul 2019 | A1 |
| 20190201623 | Kiani | Jul 2019 | A1 |
| 20190209025 | Al-Ali | Jul 2019 | A1 |
| 20190214778 | Scruggs et al. | Jul 2019 | A1 |
| 20190216319 | Poeze et al. | Jul 2019 | A1 |
| 20190216379 | Al-Ali et al. | Jul 2019 | A1 |
| 20190221966 | Kiani et al. | Jul 2019 | A1 |
| 20190223804 | Blank et al. | Jul 2019 | A1 |
| 20190231199 | Al-Ali et al. | Aug 2019 | A1 |
| 20190231241 | Al-Ali et al. | Aug 2019 | A1 |
| 20190231270 | Abdul-Hafiz et al. | Aug 2019 | A1 |
| 20190239787 | Pauley et al. | Aug 2019 | A1 |
| 20190239824 | Muhsin et al. | Aug 2019 | A1 |
| 20190254578 | Lamego | Aug 2019 | A1 |
| 20190261857 | Al-Ali | Aug 2019 | A1 |
| 20190320906 | Olsen | Oct 2019 | A1 |
| 20200060869 | Telfort et al. | Feb 2020 | A1 |
| 20200111552 | Ahmed | Apr 2020 | A1 |
| 20200113520 | Abdul-Hafiz et al. | Apr 2020 | A1 |
| 20200138368 | Kiani et al. | May 2020 | A1 |
| 20200163597 | Dalvi et al. | May 2020 | A1 |
| 20200253474 | Muhsin et al. | Aug 2020 | A1 |
| 20200253544 | Belur Nagaraj et al. | Aug 2020 | A1 |
| 20200275841 | Telfort et al. | Sep 2020 | A1 |
| 20200288983 | Telfort et al. | Sep 2020 | A1 |
| 20200329983 | Al-Ali et al. | Oct 2020 | A1 |
| 20200329993 | Al-Ali et al. | Oct 2020 | A1 |
| 20210022628 | Telfort et al. | Jan 2021 | A1 |
| 20210104173 | Pauley et al. | Apr 2021 | A1 |
| 20210113121 | Diab et al. | Apr 2021 | A1 |
| 20210117525 | Kiani et al. | Apr 2021 | A1 |
| 20210118581 | Kiani et al. | Apr 2021 | A1 |
| 20210121582 | Krishnamani et al. | Apr 2021 | A1 |
| 20210161465 | Barker et al. | Jun 2021 | A1 |
| 20210236729 | Kiani et al. | Aug 2021 | A1 |
| 20210256835 | Ranasinghe et al. | Aug 2021 | A1 |
| 20210275101 | Vo et al. | Sep 2021 | A1 |
| 20210290072 | Forrest | Sep 2021 | A1 |
| 20210290080 | Ahmed | Sep 2021 | A1 |
| 20210290120 | Al-Ali | Sep 2021 | A1 |
| 20210290177 | Novak, Jr. | Sep 2021 | A1 |
| 20210290184 | Ahmed | Sep 2021 | A1 |
| 20210296008 | Novak, Jr. | Sep 2021 | A1 |
| 20210330228 | Olsen et al. | Oct 2021 | A1 |
| 20210386382 | Olsen et al. | Dec 2021 | A1 |
| 20210402110 | Pauley et al. | Dec 2021 | A1 |
| 20220039707 | Sharma et al. | Feb 2022 | A1 |
| 20220053892 | Al-Ali et al. | Feb 2022 | A1 |
| 20220071562 | Kiani | Mar 2022 | A1 |
| 20220096603 | Kiani et al. | Mar 2022 | A1 |
| 20220151521 | Krishnamani et al. | May 2022 | A1 |
| 20220218244 | Kiani et al. | Jul 2022 | A1 |
| 20220287574 | Telfort et al. | Sep 2022 | A1 |
| 20220296161 | Al-Ali et al. | Sep 2022 | A1 |
| 20220361819 | Al-Ali et al. | Nov 2022 | A1 |
| 20220379059 | Yu et al. | Dec 2022 | A1 |
| 20220392610 | Kiani et al. | Dec 2022 | A1 |
| 20230028745 | Al-Ali | Jan 2023 | A1 |
| 20230038389 | Vo | Feb 2023 | A1 |
| 20230045647 | Vo | Feb 2023 | A1 |
| 20230058052 | Ai-Ai | Feb 2023 | A1 |
| 20230058342 | Kiani | Feb 2023 | A1 |
| 20230069789 | Koo et al. | Mar 2023 | A1 |
| 20230087671 | Telfort et al. | Mar 2023 | A1 |
| 20230110152 | Forrest et al. | Apr 2023 | A1 |
| 20230111198 | Yu et al. | Apr 2023 | A1 |
| 20230115397 | Vo et al. | Apr 2023 | A1 |
| 20230116371 | Mills et al. | Apr 2023 | A1 |
| 20230135297 | Kiani et al. | May 2023 | A1 |
| 20230138098 | Telfort et al. | May 2023 | A1 |
| 20230145155 | Krishnamani et al. | May 2023 | A1 |
| 20230147750 | Barker et al. | May 2023 | A1 |
| 20230210417 | Al-Ali et al. | Jul 2023 | A1 |
| 20230222805 | Muhsin et al. | Jul 2023 | A1 |
| 20230222887 | Muhsin et al. | Jul 2023 | A1 |
| 20230226331 | Kiani et al. | Jul 2023 | A1 |
| 20230284916 | Telfort | Sep 2023 | A1 |
| 20230284943 | Scruggs et al. | Sep 2023 | A1 |
| 20230301562 | Scruggs et al. | Sep 2023 | A1 |
| 20230346993 | Kiani et al. | Nov 2023 | A1 |
| Number | Date | Country |
|---|---|---|
| 2262236 | Apr 2008 | CA |
| 0716628 | Dec 1998 | EP |
| 0659058 | Jan 1999 | EP |
| 1207536 | May 2002 | EP |
| 2358546 | Nov 1999 | GB |
| 6214898 | Jan 1987 | JP |
| 01-309872 | Jun 1998 | JP |
| 10-155755 | Jun 1998 | JP |
| 2001-50713 | May 1999 | JP |
| 2003-329719 | Nov 2003 | JP |
| WO 1994005207 | Mar 1994 | WO |
| WO 1994013207 | Jun 1994 | WO |
| WO 1995029632 | Nov 1995 | WO |
| WO 1999053277 | Oct 1999 | WO |
| WO 2000010462 | Mar 2000 | WO |
| WO 2001034033 | May 2001 | WO |
| WO 2001078059 | Oct 2001 | WO |
| WO 2001097691 | Dec 2001 | WO |
| WO 2002003042 | Jan 2002 | WO |
| WO 2003058646 | Jul 2003 | WO |
| WO 2003087737 | Oct 2003 | WO |
| WO 2004000111 | Dec 2003 | WO |
| WO 2004004411 | Jan 2004 | WO |
| WO 2005096931 | Oct 2005 | WO |
| WO 2005099562 | Oct 2005 | WO |
| WO 2008017246 | Feb 2008 | WO |
| WO 2008080469 | Jul 2008 | WO |
| WO 2008148172 | Dec 2008 | WO |
| WO 2009093159 | Jul 2009 | WO |
| WO 2009137524 | Nov 2009 | WO |
| Entry |
|---|
| US 8,845,543 B2, 09/2014, Diab et al. (withdrawn) |
| US 9,579,050 B2, 02/2017, Al-Ali (withdrawn) |
| U.S. Appl. No. 15/851,176, Non-Invasive Monitoring of Respiratory Rate, Heart Rate and Apnea, filed Dec. 21, 2017. |
| U.S. Appl. No. 16/557,198, Acoustic Physiological Monitoring System, filed Aug. 30, 2019. |
| U.S. Appl. No. 16/155,456, Acoustic Respiratory Event Processor, filed Oct. 9, 2018. |
| U.S. Appl. No. 16/119,215, Plethysmographic Respiration Processor, filed Aug. 31, 2018. |
| U.S. Appl. No. 16/459,955, Respiration Event Processor, filed Jul. 2, 2019. |
| U.S. Appl. No. 13/900,984, Plethysmographic Respiration Analysis System, filed May 23, 2013. |
| Analog Devices, 12-Bit Serial Input Multiplying D/A Converter, Product Data Sheet, 2000. |
| Chambrin, M-C.; “Alarms in the intensive care unit: how can the number of false alarms be reduced?”; Critical Care Aug. 2001, vol. 5 No. 4; p. 1-5. |
| Eldor et al., “A device for monitoring ventilation during anaesthesia; the paratracheal audible respiratory monitor”, Canadian Journal of Anaesthesia, 1990, vol. 9, No. 1, p. 95-98. |
| GE Healthcare, “Transport ProTM Patient Monitor Operator's Manual” Apr. 9, 2007, in 286 pages. |
| Gorges, M. et al; “Improving Alarm Performance in the Medical Intensive Care Unit Using Delays and Clinical Context”; Technology, Computing, and Simulation; vol. 108, No. 5, May 2009; p. 1546-1552. |
| Imhoff, M. et al; “Alarm Algorithms in Critical Care Monitoring”; Anesth Analg 2006;102:1525-37. |
| International Search Report & Written Opinion, PCT Application PCT/US2010/052758, dated Feb. 10, 2011; 12 pages. |
| International Search Report & Written Opinion, PCT Application PCT/US2010/058981, dated Feb. 17, 2011; 11 pages. |
| International Search Report and Written Opinion issued in application No. PCT/US2010/052756 dated Feb. 6, 2012. |
| International Search Report, PCT Application PCT/CA2003/000536, dated Dec. 11, 2003; 2 pages. |
| International Search Report, PCT Application PCT/US2009/069287, dated Mar. 30, 2010; 7 pages. |
| Japanese Office Action for JP Application No. 2007-506626 dated Mar. 1, 2011. |
| Sierra et al., Monitoring Respiratory Rate Based on Tracheal Sounds. First Experieances, Proceedings of the 26th Annual Int'l Conf. of the IEEE EMBS (Sep. 2004), 317-320. |
| Watt, R. C.; “Alarms and Anesthesia. Challenges in the design of Intelligent systems for Patient Monitoring”; IEEE Engineering in Medicine and biology; Dec. 1993, p. 34-41. |
| Welch Allyn, ECG ASIC, Product Data Sheete, 2001. |
| Supplementary Partial European Search Report for International Application No. 05732095.4, dated Jun. 26, 2009 in 4 pages. |
| Theimer et al., “Definitions of audio features for music content description”, Algorithm Engineering Report TR08-2-001, Feb. 2008. |
| Stewart, C., Larson, V., “Detection and classification of acoustic signals from fixed-wing aircraft,” Systems Engineering, CH3051-0/91/0000-0025, IEEE, 1991. |
| Johnston, Development of a Signal Processing Library for Extraction of Sp02, HR, HRV, and RR from Photoplethysmographic Waveforms, Thesis: Degree of Master of Science, Worcester Polytechnic Institute, date of presentation/defense Jul. 17, 2006, date listed Jul. 27, 2006. |
| Hsu, “Signals and Systems”, Schaum's Theory and Problems, 1995, Ch. 3, p. 121. |
| Smith, “The Scientist and Engineer's Guide to Digital Signal Processing”, https://www.dspguide.com/ch17/2.htm, Ch. 17 and Ch. 18, 2 book editions, original 1997, updated 2002, pp. 297-318. |
| Number | Date | Country | |
|---|---|---|---|
| 20200253509 A1 | Aug 2020 | US |
| Number | Date | Country | |
|---|---|---|---|
| 61326200 | Apr 2010 | US | |
| 61252594 | Oct 2009 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 15669201 | Aug 2017 | US |
| Child | 16791241 | US | |
| Parent | 12905384 | Oct 2010 | US |
| Child | 15669201 | US |
